SIGNALING MECHANISMS THAT CONTROL GAP JUNCTIONAL COUPLING BETWEEN RETINAL NEURONS by Kothmann, Wade
Texas Medical Center Library
DigitalCommons@The Texas Medical Center
UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences
5-2010
SIGNALING MECHANISMS THAT
CONTROL GAP JUNCTIONAL COUPLING
BETWEEN RETINAL NEURONS
Wade Kothmann
Follow this and additional works at: http://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Molecular and Cellular Neuroscience Commons
This Dissertation (PhD) is brought to you for free and open access by the
Graduate School of Biomedical Sciences at DigitalCommons@The Texas
Medical Center. It has been accepted for inclusion in UT GSBS
Dissertations and Theses (Open Access) by an authorized administrator of
DigitalCommons@The Texas Medical Center. For more information,
please contact laurel.sanders@library.tmc.edu.
Recommended Citation
Kothmann, Wade, "SIGNALING MECHANISMS THAT CONTROL GAP JUNCTIONAL COUPLING BETWEEN RETINAL
NEURONS" (2010). UT GSBS Dissertations and Theses (Open Access). Paper 18.
SIGNALING MECHANISMS THAT CONTROL GAP JUNCTIONAL 
COUPLING BETWEEN RETINAL NEURONS 
by 
W. Wade Kothmann 
 
 
 
APPROVED: 
 
 
______________________________________ 
John O’Brien, Ph.D., Supervisory Professor 
 
 
______________________________________ 
Carmen W. Dessauer, Ph.D. 
 
 
______________________________________ 
Stephen C. Massey, Ph.D. 
 
 
______________________________________ 
Stephen L. Mills, Ph.D. 
 
 
______________________________________ 
Daniel S. Wagner, Ph.D. 
 
 
 
APPROVED: 
 
 
______________________________________ 
Dean, The University of Texas Graduate School of Biomedical Sciences 
 
SIGNALING MECHANISMS THAT CONTROL GAP JUNCTIONAL 
COUPLING BETWEEN RETINAL NEURONS 
 
 
 
A 
 
DISSERTATION 
 
Presented to the Faculty of 
The University of Texas  
Health Science Center at Houston 
and 
The University of Texas 
M.D. Anderson Cancer Center 
Graduate School of Biomedical Sciences 
in Partial Fulfillment  
 
of the Requirements 
 
for the Degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
by 
 
William Wade Kothmann 
Houston, Texas 
 
May 2010 
 
 
  
 
 
This work is dedicated to my family 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
Acknowledgements 
 
 There are so many people to thank for their roles in shaping both the work presented 
here and my development as a scientist.  First and foremost among them is my advisor, 
John O’Brien.  When I came to John and expressed my interest in his research, I had very 
little background in molecular and cellular neuroscience.  Despite this, John accepted me 
as a rotation student and then as his graduate trainee, thus setting off the chain of events 
that has led to this dissertation.  In addition, a number of other things have come to be 
because of that first step, including what I expect will be my lifelong fascination with the 
retina and visual science.  John has been the consummate mentor to me, providing his 
advice and guidance at every step of my training while also allowing me a degree of 
autonomy in selecting my research model and experimental directions.  The fact that his 
door remains open daily and that I have so rarely ever had to wait a day or even an hour 
to discuss my latest data or thoughts with him is, in my opinion, one of his best qualities.  
The example he has set is one I hope to follow one day, should I have the opportunity to 
train students of my own. 
 The faculty members of the Ophthalmology department have also been invaluable 
teachers and friends to me in Houston.  My weekly trips to the Ginger Man with Steve 
Massey will be sorely missed, as will all the conversations and advice, scientific and 
otherwise.  I am also quite certain that most of my developmental strides in confocal 
microscopy are due to that first, half-in-jest comment he made on one of my images.  I 
am grateful for the many discussions I’ve had with Steve Mills here and at ARVO, and 
for all his insight and thoughtful comments.  Finally, Steven Wang has set an example of 
iv 
how to work hard and then play hard, and I am grateful as well for his advice, 
encouragement, and friendship. 
 I have made many lasting friendships while at UT, and I am especially glad to have 
met Matt Swulius.  Matt has become a good friend of mine, and has provided much 
perspective on neuroscience and graduate school during our time here.  I am also glad to 
have had good labmates throughout my time in John’s lab, especially Hongyan Li. 
 Finally, I want to acknowledge my family.  My parents, Don and Sheila Kothmann, 
my sister, Kara Kothmann, and my grandparents, Hildegarde Kothmann and Jesse and 
Louise Gregg, are all inspirations to me and their constant love and support is the best 
thing in my life.  Meeting my wife, Vani Pariyadath, is without question the best thing 
that happened to me in graduate school, and I look forward to many years of life, love, 
and learning with her.  There is nothing in the world more valuable to me than my family, 
nor anyone who has shaped me more than them; thus, as with everything I hope to 
accomplish, this is for them. 
 
 
 
 
 
 
 
 
 
v 
Abstract 
 
Signaling mechanisms that control gap junctional coupling between 
retinal neurons 
 
Gap junctions between neurons form the structural substrate for electrical synapses.  
Connexin 36 (Cx36, and its non-mammalian ortholog connexin 35) is the major neuronal 
gap junction protein in the central nervous system (CNS), and contributes to several 
important neuronal functions including neuronal synchronization, signal averaging, 
network oscillations, and motor learning.  Connexin 36 is strongly expressed in the retina, 
where it is an obligatory component of the high-sensitivity rod photoreceptor pathway.  A 
fundamental requirement of the retina is to adapt to broadly varying inputs in order to 
maintain a dynamic range of signaling output.  Modulation of the strength of electrical 
coupling between networks of retinal neurons, including the Cx36-coupled AII amacrine 
cell in the primary rod circuit, is a hallmark of retinal luminance adaptation.  However, 
very little is known about the mechanisms regulating dynamic modulation of Cx36-
mediated coupling.  The primary goal of this work was to understand how cellular 
signaling mechanisms regulate coupling through Cx36 gap junctions.  We began by 
developing and characterizing phospho-specific antibodies against key regulatory 
phosphorylation sites on Cx36.  Using these tools we showed that phosphorylation of 
Cx35 in fish models varies with light adaptation state, and is modulated by acute changes 
in background illumination.  We next turned our focus to the well-studied and readily 
identifiable AII amacrine cell in mammalian retina.  Using this model we showed that 
vi 
increased phosphorylation of Cx36 is directly related to increased coupling through these 
gap junctions, and that the dopamine-stimulated uncoupling of the AII network is 
mediated by dephosphorylation of Cx36 via protein kinase A-stimulated protein 
phosphatase 2A activity.  We then showed that increased phosphorylation of Cx36 on the 
AII amacrine network is driven by depolarization of presynaptic ON-type bipolar cells as 
well as background light increments.  This increase in phosphorylation is mediated by 
activation of extrasynaptic NMDA receptors associated with Cx36 gap junctions on AII 
amacrine cells and by Ca2+-calmodulin-dependent protein kinase II activation.  Finally, 
these studies indicated that coupling is regulated locally at individual gap junction 
plaques.  This work provides a framework for future study of regulation of Cx36-
mediated coupling, in which increased phosphorylation of Cx36 indicates increased 
neuronal coupling. 
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1 
Gap Junctions: An Overview 
  Gap junctions are membrane-bound, dodecameric protein channels that 
connect two neighboring cells by forming an aqueous pore through which metabolic and 
electrical communication can occur.  These channels aggregate into plaques in the lipid 
bilayer which contain from tens to thousands of individual gap junctions (Yeager, 2009).  
Each individual gap junction is composed of two docked hemichannels, or connexons, 
one hemichannel being contributed by each cell in a coupled pair of cells.  Each 
hemichannel is in turn composed of six protein subunits called connexins, which are 
organized as a hexagonal ring to form the pore (Yeager, 2009).  Connexin subunits each 
contain four transmembrane domains, as well as two characteristic extracellular loops 
which mediate the docking interaction (Yeager, 2009).  The remaining intracellular 
components (N-terminus, intracellular loop, and C-terminal tail) show considerable 
variability across different connexin genes and are targets for regulation of the protein 
(Lampe and Lau, 2004). 
  The human connexin gene family has 21 members, while only 20 are known 
in mice (Beyer and Berthoud, 2009).  Connexin genes are expressed in virtually every 
tissue in the body over the course of development, and in adulthood gap junctions are 
found in most organs.  A number of connexin genes are also linked to diseases, which 
due to the wide expression of the various connexin proteins range from genetic 
neuropathies to various skin diseases, from congenital deafness to cataracts (Beyer and 
Berthoud, 2009).  The work presented hereafter will focus on the role of gap junctions in 
the central nervous system (CNS). 
 
2 
Gap Junctions in Neurons: Basic Properties 
  Gap junctions between neurons form the structural substrate for electrical 
synapses.  Because gap junctions form aqueous pores which are permeable to the 
common ions used by neurons to control their membrane voltage (Na+, K+, Ca2+, Cl-), 
when two neurons coupled by a gap junction have unequal membrane potentials current 
will flow through the gap junction proportional to the size of the voltage difference.  Thus 
gap junctions between neurons act as Ohmic resistors. 
  Communication between two neurons through electrical synapses contrasts in 
several ways with the more common chemical synapses.  First, electrical synapses are 
faster than chemical synapses since there is no delay imposed by release, diffusion, and 
binding of neurotransmitter molecules to receptors.  Second, electrical synapses are 
always sign conserving; depolarization of one cell in a coupled pair will always cause a 
depolarization in the second coupled cell.  Third, electrical synapses do not (in and of 
themselves) show signal amplification; depolarization of one cell in a coupled pair will 
cause a smaller depolarization in the second coupled cell inversely proportional to the 
resistance of the gap junctions.  The ratio voltage change in the second cell to voltage 
change in the first (initially depolarized) cell is termed the coupling coefficient.  
Additionally, when the input resistances of a coupled cell pair are unequal, the cell with 
the lower input resistance will exert a greater influence on the cell with the higher input 
resistance.  Finally, electrical synapses are bidirectional, as a depolarization in either cell 
relative to the other will cause current to flow through the gap junctions. 
  Despite the many differences between electrical and chemical synapses, they 
do share some common functional properties, although the underlying causes of the 
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properties may be different.  For instance, electrical synapses undergo synaptic 
potentiation (short- and long-term) and depression (Yang et al., 1990; Pereda and Faber, 
1996; Landisman and Connors, 2005), similar to chemical synapses.  The major goal of 
the research presented herein was to further understand the molecular processes that 
underlie regulation of gap junctional coupling in neurons.  These processes are likely to 
be the basis for potentiation and depression observed at electrical synapses.  
 
Gap Junctions in Neurons: Connexin Identity and Implications for Disease 
  A number of connexins are expressed in neurons in the CNS, including 
Cx30.2, Cx36, Cx37, Cx40, Cx45, Cx50, and Cx57 (Massey et al., 2003; Kreuzberg et 
al., 2008; Connors, 2009).  Of these, Cx36 is both the best studied and the most widely 
expressed in the CNS (Connors, 2009).  Cx36 gap junction expression occurs throughout 
the brain, but is particularly notable in the retina, olfactory bulb, hippocampus, 
cerebellum, cerebral cortex, reticular nucleus of the thalamus, inferior olive, striatum, and 
spinal cord (Condorelli et al., 1998).  In many of these regions specific cell types coupled 
by Cx36 have been identified and studied (Connors, 2009). 
  Neuronal coupling via gap junctions has been suggested to contribute to the 
generation and maintenance of neural synchrony underlying seizures (Carlen et al., 2000; 
Perez Velazquez and Carlen, 2000).  The gene coding for Cx36 has been associated by 
linkage studies with juvenile myoclonic epilepsy (Mas et al., 2004; Hempelmann et al., 
2006), and experimental studies have provided some further support for a role of Cx36 in 
epilepsy (Maier et al., 2002).  These include observations that induced epileptiform 
activity is reduced in Cx36-null mice and altered Cx36 expression in animal models of 
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epilepsy (Sohl et al., 2000; Gajda et al., 2003; McCracken and Roberts, 2006).  
Additionally, drugs that block gap junctional coupling have anticonvulsive effects in 
seizure models, including drugs with partial specificity for Cx36 (Jahromi et al., 2002; 
Uusisaari et al., 2002; Gajda et al., 2003; Gajda et al., 2005; Bostanci and Bagirici, 2007).  
Thus, understanding the mechanisms which mediate regulated changes in coupling 
through Cx36 gap junctions may have future relevance for novel epilepsy interventions. 
 
Connexin 36: Channel Properties 
  Cx36 gap junctions have the smallest unitary conductance, around 10-15 pS, 
measured out of all functional gap junction channels (Srinivas et al., 1999; Teubner et al., 
2000).  Coupling through Cx36 gap junctions is relatively insensitive to transjunctional 
voltage changes (Srinivas et al., 1999), making them ideal for electrical communication 
between neurons.  Intracellular acidification causes minor increases in the conductance of 
Cx36 gap junctions, while alkilinization causes a somewhat sharper reduction of 
conductance (Gonzalez-Nieto et al., 2008).  However, modulation of channel 
conductance by pH within physiological ranges alters conductance less than 25% from 
baseline coupling at pH 7.25. 
  Studies using small tracer molecules have indicated that Cx36 shows some 
charge selectivity, preferentially passing positively charged tracers while restricting 
diffusion of negatively charged tracers (Vaney, 1985, , 1991; Mills et al., 2001b; 
Charpantier et al., 2007).  The preferred tracer for studying Cx36 has been biotin 
ethylenediamine (Neurobiotin; MW 286 Da, net charge +1), which readily diffuses 
through these junctions.  Larger biotin-conjugated tracers show increasingly reduced 
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permeability through Cx36 junctions as size increases, with biotin-XX cadaverine (MW 
555 Da, net charge +1) showing ~80% reduced permeability (Mills and Massey, 2000).  
Negatively charged tracers within the same size range (Lucifer yellow, MW 443 Da, net 
charge -2; 6-carboxyfluorescein, MW 376 Da, net charge -1) show very little permeation 
of Cx36 gap junctions (Vaney, 1985, , 1991; Charpantier et al., 2007). 
  Fewer studies have addressed the permeation of Cx36 by more biologically 
relevant molecules.  It has been shown that Cx36 is relatively impermeant to the second 
messenger cAMP (Bedner et al., 2003; Bedner et al., 2006), which is not surprising given 
its net negative charge.  It is known that Ca2+ permeates Cx36 gap junctions (citations), 
which is quite significant for neuronal signaling. 
 
Connexin 36: Role in Neuronal Circuits 
  Owing to its wide expression throughout the CNS, it is not surprising that a 
number of studies have identified important roles of Cx36 in neuronal function.  Multiple 
types of inhibitory interneurons are electrically coupled in neocortex, where they drive 
synchronized inhibition of excitatory neurons (Gibson et al., 1999; Beierlein et al., 2000).  
Cx36 gap junctions are critical for the generation of this synchronous inhibition (Deans et 
al., 2001).  Electrical coupling of neurons in the reticular nucleus of the thalamus by 
Cx36 gap junctions likewise mediate correlated spiking patterns within these neurons, 
which in turn provide inhibition onto thalamic relay cells (Landisman et al., 2002; Long 
et al., 2004).  Cx36 gap junctions between neurons in the inferior olive mediate 
synchronization of subthreshold membrane oscillations (Long et al., 2002).  Loss of Cx36 
gap junctions between these olivary neurons causes deficits in cerebellar motor learning 
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(Van Der Giessen et al., 2008).  Cx36-null mice also show selective impairment of 
gamma-frequency oscillation in the hippocampus (Hormuzdi et al., 2001; Buhl et al., 
2003)., which are thought to be involved in binding of spatially separated information 
processing. 
  In the retina, Cx36 gap junctions are expressed by every class of neuron 
except horizontal cells (Feigenspan et al., 2001a; Mills et al., 2001b; Hidaka et al., 2002; 
Lee et al., 2003; Feigenspan et al., 2004a; Zhang and Wu, 2004; Han and Massey, 2005; 
Schubert et al., 2005).  Coupling between photoreceptors leads to signal averaging 
between neighbors which can lead to significant improvement of the signal to noise ratio 
(Schwartz, 1975c; Lamb and Simon, 1976; DeVries et al., 2002) and also expands the 
effective voltage response range of rods (Attwell et al., 1987).  Additionally, coupling 
between rods and cones provides an alternative pathway for rod signals to enter the cone 
circuitry (Schwartz, 1975d; Deans et al., 2002; Bloomfield and Volgyi, 2009).  Coupling 
between retinal ganglion cells, many of which express Cx36 (Pan et al., ; Hidaka et al., 
2002; Schubert et al., 2005), contributes to synchronous spiking activity (Hu and 
Bloomfield, 2003). 
  Perhaps the best known function of Cx36 gap junctions in the retina is 
coupling between AII amacrine neurons (Kolb and Famiglietti, 1974; Famiglietti and 
Kolb, 1975; Feigenspan et al., 2001a; Mills et al., 2001b; Veruki and Hartveit, 2002a).  
AIIs receive excitatory input from rod bipolar cells (Kolb and Famiglietti, 1974; Strettoi 
et al., 1990), and share this input with their neighboring AIIs through Cx36 gap junctions.  
The AII network also outputs the signal through gap junctions, which are composted of 
Cx36 on the AII side, to ON-cone bipolar cells (Kolb and Famiglietti, 1974; Mills and 
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Massey, 1995; Mills et al., 2001b; Veruki and Hartveit, 2002b).  Since rod bipolar cells 
do not synapse onto retinal ganglion cells, loss of Cx36 eliminates transmission through 
the primary, high-gain rod photoreceptor pathway (Deans et al., 2002; Volgyi et al., 
2004).  In addition to the loss of this direct pathway for ON signals, loss of Cx36 also 
eliminates the highest-sensitivity OFF pathway, which relies on glycine release from the 
lobular dendrites on AII amacrine cells (Volgyi et al., 2004).  Loss of Cx36 does not 
directly prevent this inhibitory output from the AII, but rather lowers its sensitivity to 
light.  This is because coupling between AIIs is thought to underlie summation of 
synchronous signals and subtraction of asynchronous noise at very low light-levels, thus 
increasing the overall sensitivity of the cells output (Smith and Vardi, 1995; Vardi and 
Smith, 1996; Bloomfield and Volgyi, 2004). 
 
The Retina: An Overview 
  Human vision begins when photoreceptor neurons in the retina transduce 
absorbed photons into electrical signals.  These signals diverge from a small number of 
photoreceptor types (one high-sensitivity rod photoreceptor and three [or two to five, in 
other vertebrates] lower-sensitivity cone photoreceptor types with differing spectral 
sensitivities) at glutamatergic synapses onto a larger number (roughly 10, depending on 
species) of bipolar cell types.  Bipolar cell types are broadly classified into types that 
depolarize to light increments (ON-types, which includes the single type of rod bipolar 
cell), and types that hyperpolarize to light (OFF-types).  Signals in bipolar cells then 
diverge further at glutamatergic synapses onto a larger number (between 15 and 20, 
depending on species) of ganglion cell types.  These ganglion cells then output the 
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information processed in the retina to the rest of the brain as spike trains carried along 
their axons, forming a number of parallel information pathways equal to the number of 
ganglion cell types (Roska and Werblin, 2001; Dacey et al., 2003; Roska et al., 2006; 
Field and Chichilnisky, 2007).  Each pathway carries information extracted from 
particular components that make up the visual environment, which will then be further 
processed by higher-order neurons in the brain to give rise to visual perception (Roska 
and Werblin, 2001; Dacey et al., 2003; Roska et al., 2006; Field and Chichilnisky, 2007). 
  In addition to fundamental differences in the biophysical properties of 
photoreceptors, bipolar cells, and ganglion cells, two key components of retinal circuitry 
necessary for fine-tuning each parallel pathway are horizontal and amacrine cell 
inhibitory interneurons.  Horizontal cells (between 2 and 4, depending on species) and 
amacrine cells (25 types and up, depending on species) are thought to contribute largely 
to the spatial and temporal processing properties of photoreceptors, bipolar cells, and 
ganglion cells (Roska and Werblin, 2001; Roska et al., 2006; Field and Chichilnisky, 
2007). 
 
The Necessity of Adaptation 
  In addition to the divergence of photoreceptor signals detailed above, there is 
also a high degree of convergence evident in many retinal pathways, especially the rod 
photoreceptor pathway (Volgyi et al., 2004; Dunn et al., 2006).  Because signals from up 
to 10,000 rods may converge onto one ganglion cell the retina has exquisite sensitivity to 
light, but is also in constant danger of saturation (Dunn et al., 2006).  And although the 
various specializations of the retina allow us to perceive the visual world over at least a 
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109-fold range of background light intensities, the output range of retinal ganglion cells 
(in terms of spike rate modulation) is only 102 (Rodieck, 1998; Rieke and Rudd, 2009).  
Thus adaptation is absolutely necessary to preserve dynamic range of signaling, 
preventing saturation yet preserving our ability to perceive meaningful differences in our 
environment.  Adaptation takes place at many different levels in the retina, from the 
biochemical phototransduction cascade in photoreceptors (Rodieck, 1998) to individual 
synapses between retinal neurons (Rieke and Rudd, 2009; Wark et al., 2009).  One 
hallmark of luminance adaptation in the retina is regulated changes in coupling between 
horizontal cells and AII amacrine cells (Xin and Bloomfield, 1997, , 1999; Bloomfield 
and Volgyi, 2004).   
 
The Role of Connexin 36 in Retinal Adaptation 
  Both types of rabbit horizontal cells and AII amacrine cells display inverted 
“U”-shaped coupling functions with relation to background light intensity (Xin and 
Bloomfield, 1997, , 1999; Bloomfield and Volgyi, 2004).  Since horizontal cells do not 
use Cx36, the focus here will be on the role of regulated coupling changes in AII 
amacrine cells.  AIIs are relatively uncoupled in well dark-adapted retina, when ambient 
background light is below rod photoreceptor threshold.  Increasing background 
illumination to just above rod photoreceptor threshold sharply increases coupling, both 
electrical (as measured by receptive field size) and tracer (Neurobiotin diffusion), 4 to 5-
fold.  Coupling continues to increase along a much shallower trajectory as background 
illumination is raised over several log units, until eventually it again decreases somewhat 
sharply back towards baseline levels.  As dopamine also uncouples AII amacrine cells via 
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activation of D1 receptors (Hampson et al., 1992; Mills and Massey, 1995), and since 
dopamine is considered a light-adaptive signal in the retina (Witkovsky, 2004) that is 
released by light-stimulation (Mills et al., 2007; Zhang et al., 2007), it is widely thought 
that the falloff in coupling at higher background intensities is mediated by dopamine 
signaling.  Less attention has been given to potential mechanisms underlying the 
background light-driven increase in coupling, although it has the appearance of an 
activity-dependent process. 
  Much thought has been given to the functional significance of regulated 
changes in AII amacrine cell coupling in retinal adaptation.  The prevailing line of 
thinking is that AIIs are uncoupled in darkness in order to maximize the effect of any 
single-photon absorptions in individual rods.  When photons are this scarce, preventing 
the lateral spread of depolarization in the AII network will enhance the transfer of the 
signal into coupled ON-cone bipolar cells and then on to a ganglion cell.  As background 
illumination increases to a level reliably above rod threshold, the chance increases that 
two rods within a given distance of each other will absorb photons within the same 
integration period.  In such a case, much enhanced coupling between AIIs will allow the 
summation of synchronous signals and subtraction of asynchronous signals, as noted 
previously.  Computational modeling (Vardi and Smith, 1996) and experimental evidence 
(Dunn et al., 2006) support this, demonstrating that coupling in the AII network increases 
the signal to noise ratio of the AII’s light response.  The further increase in coupling as 
lighting increases in the scotopic range may contribute to gain control as well, as 
shunting of increasing excitatory currents in AIIs caused by increasing rod bipolar input 
may help to prevent saturation.  Finally, as background light enters the cone-
11 
photoreceptor operating range, uncoupling of AIIs likely serves a two-fold purpose.  
First, it likely optimizes the amount of rod input and cone input mixing in cone bipolar 
cells in the mesopic range where both rods and cones are active.  Second, as background 
light enters the photopic range the AII switches its “duty” and receives its input directly 
from coupled ON-cone bipolar cells, triggering release of glycine by the AII onto OFF-
cone bipolar cells and some ganglion cells (Manookin et al., 2008; Murphy and Rieke, 
2008; Munch et al., 2009; van Wyk et al., 2009).  Uncoupling of the AII network in this 
range will increase the spatial localization of this inhibition when photons are abundant 
enough to activate the cone pathways of the retina. 
 
Regulation of Connexin 36: Initial Studies 
  Coupling at AII-AII gap junctions is preferentially regulated by dopamine 
signaling and cAMP-dependent processes, while coupling between AII-cone bipolar gap 
junctions is preferentially regulated by nitric oxide signaling and cGMP-dependent 
processes (Mills and Massey, 1995).  Alteration of protein kinase activity is a common 
effector of these pathways, and thus initial studies of the regulation of Cx36 targeted 
kinase pathways.  Addition of a cAMP analog was shown to reduce currents through 
Cx35 gap junctions expressed in Xenopus oocytes, and this reduction required a PKA 
consensus sequence (Mitropoulou and Bruzzone, 2003).  Further studies in HeLa cells 
stably transfected with fish Cx35 identified two phosphorylation sites, Ser110 and Ser276 
were required for regulation of coupling by PKA activity (Ouyang et al., 2005).  
Activation of PKA caused decreased HeLa coupling in these experiments, while 
inhibition of PKA increased coupling.  Serine to alanine mutation of either residue alone 
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reduced regulation by PKA activity, while mutation of both sites eliminated this 
regulation.  Repeating these experiments with HeLa cells transiently transfected with 
mouse Cx36 showed that this regulation by PKA activity is conserved at both 
phosphorylation sites in mammals (our unpublished observations).  Several studies have 
indicated that multiple kinases can phosphorylate both of these sites in vitro, including 
PKA, PKG, and CamKII (Ouyang et al., 2005; Patel et al., 2006; Urschel et al., 2006).  
Other kinases are predicted or known to phosphorylate one or the other of these sites 
(Ouyang et al., 2005; Urschel et al., 2006).  The convergence of multiple kinases, 
representing the effectors of various signaling pathways, upon each of these 
phosphorylation sites suggests their critical involvement in regulation of Cx36-mediated 
coupling. 
  In addition to phosphorylation, protein-protein interactions are also likely to 
contribute to regulation of Cx36-mediated coupling.  It is known that calmodulin binds to 
the C-terminal tail of Cx36 with a low-micromolar K1/2 for Ca2+ (Burr et al., 2005).  The 
necessity of this relatively high intracellular concentration of Ca2+ for binding indicates 
that this interaction would likely be most common at sites such as synapses, where such 
elevations of Ca2+ occur.  The functional significance of calmodulin binding to Cx36 is 
still not well understood.  In addition to calmodulin binding, the tip of the C-terminal tail 
of Cx36 is a PDZ-domain binding target (Li et al., 2004).  This mediates known 
interactions with the PDZ-domain-containing scaffolding protein ZO-1 (Li et al., 2004; 
Flores et al., 2008), and potentially with several other scaffolding proteins.  This 
interaction likely does not regulate Cx36 directly, but evidence suggests that it is 
important for localizing regulatory proteins to the site of Cx36 gap junctions.  For 
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instance, when the tip is truncated, regulation by PKA activity is reversed, such that 
activation of PKA leads to increased coupling and vice versa (Ouyang et al., 2005).  Such 
interactions may prove to control cell-specific schemes of Cx36 regulation, particularly 
those involving different kinase or phosphatase proteins. 
 
Starting Hypotheses 
  The following work tested several hypotheses concerning the regulation of 
Cx36 by phosphorylation in retinal neurons and the signaling pathways responsible for 
this regulation.  These chapters follow one another fairly linearly as they progress 
towards their goal of furthering our understanding of the signaling mechanisms which 
control regulated changes in neuronal coupling. 
  Chapter 2 focuses on the development and characterization of antibodies 
specific for Cx35/36 proteins phosphorylated at either of the two key regulatory serine 
residues.  These antibodies have proven to be uniquely valuable tools for understanding 
how Cx36 regulation occurs in physiologically intact systems.  Following the 
characterization of the antibodies, they are used to test the hypotheses that the 
phosphorylation state of Cx36 is modulated by light-adaptation state and also by acute 
changes in background illumination. 
  Chapter 3 seeks to establish the exact relationship between the 
phosphorylation state of Cx36 gap junctions and the coupling state of the networks 
expressing them.  In it we test the hypothesis that dopamine-mediated uncoupling of AII 
amacrine cells is mediated by increased phosphorylation of Cx36.  The experimental data 
generated argued for rejection of this hypothesis.  Therefore, we then test the hypotheses 
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that dopamine-stimulated uncoupling of AII amacrine cells required PKA activation, and 
that PKA-mediated uncoupling of AII amacrine cells required activation of a protein 
phosphatase. 
  Chapter 4 explores the signaling mechanisms responsible for increasing the 
coupling of AII amacrine cells.  Based on observations of the expression pattern of 
NMDA receptors on AIIs, we test the hypotheses that NMDA receptor activation 
mediates increased phosphorylation of Cx36, and that such increases in phosphorylation 
are mediated by Ca2+ influx and activation of CamKII.  Additionally, we test whether 
influx of Ca2+ through NMDA receptors is amplified by Ca2+-induced Ca2+-release, and 
whether increased phosphorylation is mediated by activation of ON-bipolar cells either 
pharmacologically or by light increments. 
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Chapter 2 
 
Phosphorylation of connexin 35 at regulatory sites is modulated by 
light-adaptation state and acute light increments 
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“Connexin 35/36 is phosphorylated at regulatory sites in the retina” 
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Figures 1-5 in this chapter represent experiments performed by my adviser, John 
O’Brien, Ph.D. (Figures 1-4), or by a former postdoc in our lab, Xiaofan Li, Ph.D. 
(Figure 5).  Their careful work to develop and biochemically characterize the phospho-
specific antibodies against Cx35/36 laid the foundation for my experiments in the rest of 
this chapter, and indeed for the rest of my experiments in this thesis.  For this I am 
indebted to them. 
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“ 
Introduction 
Gap junctions form a key component of retinal neural circuitry, and 
are present in every major class of retinal neuron (Cook and Becker, 1995).  The 
identity of several connexins that form retinal gap junctions has been elucidated in 
the last decade.  Connexin 35/36 (O'Brien et al., 1996; Condorelli et al., 1998; 
O'Brien et al., 1998) was the first neuron-specific connexin identified.  It has been 
found in a large number of neurons in the retina and central nervous system.  In 
the retina this connexin is associated with AII amacrine cell gap junctions 
(Feigenspan et al., 2001b; Mills et al., 2001a), cone photoreceptor gap junctions 
(Feigenspan et al., 2004b; O'Brien et al., 2004), and rod photoreceptor gap 
junctions in some species (Zhang and Wu, 2004).  It is also apparent that a large 
number of other neurons use this connexin (O'Brien et al., 2004).  Disruption of 
the Cx36 gene in mice results in deficits in visual transmission through the rod 
pathway (Guldenagel et al., 2001; Deans et al., 2002), consistent with disruption 
of AII amacrine-cone ON bipolar cell and rod-cone gap junctions.  Cx36-null 
mice also showed impaired firing synchrony in the neocortex (Deans et al., 2001) 
and gamma-frequency oscillations in the hippocampus (Hormuzdi et al., 2001), as 
well as anomalous patterns of sharp-wave bursts and ripple oscillations in the 
hippocampus (Maier et al., 2002; Pais et al., 2002).   
Electrical coupling forms functional networks within which signals are 
shared, and can have many consequences.  For example, gap junctions between 
photoreceptors spread responses through adjacent terminals, improving the 
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signal:noise ratio under many conditions (Schwartz, 1975a; Lamb and Simon, 
1976), and expanding the voltage range through which a synaptic response is 
possible (Attwell et al., 1987).  Rod-cone gap junctions also provide a pathway 
through which high-sensitivity rod signals may enter the cone pathways and 
chromatic or high frequency cone signals may enter the rod pathway (Schwartz, 
1975b; Wu and Yang, 1988; Krizaj et al., 1998).   
During visual adaptation the extent of coupling between cells is 
modulated, which has significant effects on the sensitivity and resolution of the 
retina.  Light adaptation has profound effects on receptive field size and tracer 
coupling in cone-driven horizontal cells (Baldridge and Ball, 1991; Lankheet et 
al., 1993; Bloomfield et al., 1995) and AII amacrine cells (Bloomfield et al., 
1997).  Smaller but still significant changes are observed in some photoreceptors.  
Cone-cone coupling increases with light adaptation in the turtle (Copenhagen and 
Green, 1987), as does rod-cone coupling in salamander (Yang and Wu, 1989).  
These changes influence the functional efficacy of the output synapse (Smith et 
al., 1986) as well as rod input into the cone system.   
The effect of light on photoreceptors is partially mimicked by 
dopamine D2/D4-like receptor activation (Krizaj et al., 1998), which results in 
reduction of adenylyl cyclase activity and cytoplasmic cAMP concentration 
(Cohen et al., 1992; Nir et al., 2002).  In other retinal networks, the opposite 
effect is mediated by dopamine D1-type receptors.  This effect results from 
elevation of cytoplasmic cAMP and is mediated by cAMP-dependent protein 
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kinase (PKA).  It uncouples gap junctions in horizontal cells (Lasater, 1987; 
DeVries and Schwartz, 1989) and AII amacrine cells (Hampson et al., 1992).   
The effect of PKA activity on coupling in AII amacrine cells has been 
duplicated with Cx35 stably expressed in a mammalian cell line (Ouyang et al., 
2005).  Activation of PKA causes uncoupling while PKA inhibition causes an 
increase in coupling.  Uncoupling requires phosphorylation at two sites on Cx35, 
Ser110 in the intracellular loop and Ser276 in the carboxyl terminal tail.  These 
same two sites are also the target of phosphorylation by cGMP-dependent protein 
kinase (PKG) in vitro, suggesting that several signaling pathways may converge 
on these regulatory residues (Patel et al., 2006).  We reasoned that the 
phosphorylation state of Ser110 and Ser276 should be indicative of the degree of 
coupling possible through Cx35 gap junctions.  In this study we made antibodies 
against the two regulatory phosphorylation sites of Cx35 and examined whether 
these sites are phosphorylated in the retina.  A previous study has suggested that 
Cx36 is not phosphorylated in bovine retina (Sitaramayya et al., 2003).  However, 
our study finds that it is phosphorylated in both fish and mammalian retina, and 
that phosphorylation state varies with lighting conditions. 
 
Methods 
Sequence analysis 
DNA sequences obtained from GenBank were analyzed with 
GeneTool software (Biotools, Inc., Edmonton, AB) and translated to amino acid 
sequences.  Amino acid sequences were analyzed with PepTool software 
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(Biotools) to identify consensus phosphorylation sequences.  Some sequence 
alignments were performed with Clustal W (Thompson et al., 1994). 
 
Development of phospho-specific antibodies   
Phosphorylated synthetic peptides corresponding to the two major 
regulatory PKA phosphorylation sites of perch Cx35 (Ouyang et al., 2005) were 
made at the M.D. Anderson Cancer Center Synthetic Antigen Laboratory.  The 
sequence of the phosphorylated Ser110 peptide was CKERRYS(PO4)TVYLT and 
the sequence of the phosphorylated Ser276 peptide was CARRKS(PO4)IYEIRN.  
The corresponding non-phosphorylated peptides were also synthesized.  The 
phosphorylated peptides were crosslinked to Limulus hemocyanin (Sigma 
Chemical Co., St. Louis, MO) via the cysteine thiol group using N-[ε-
Maleimidocaproyloxy] succinimide ester (EMCS; Pierce Chemical Co., 
Rockford, IL).  Hemocyanin at 10 mg/ml in 83 mM NaH2PO4, 0.9 M NaCl, 10 
mM EDTA, pH 7.2 was derivatized by incubation with 1.5 mg/ml EMCS for 2 
hours at 4 ºC, and desalted over Biogel P-10 resin (Bio-Rad Laboratories, 
Hercules, CA).  For each reaction, 4.8 mg of phospho-peptide was added as dry 
solid to approximately 6 mg of derivatized hemocyanin and incubated 4 hrs at 
4°C.  Crosslinking efficiencies were approximately 50% for phospho-Ser110 
peptide and 30% for phospho-Ser276 peptide, as determined by the concentration 
of free thiol measured by derivatization with dithionitrobenzoic acid (DTNB; 
Sigma) and measurement of absorbance at 412 nm.  The hemocyanin-linked 
peptides were dialyzed for 20 hrs against PBS (137 mM NaCl, 2.7 mM KCl, 10 
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mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4), sterile filtered, and sent to Spring 
Valley Laboratories (Sykesville, MD) for development of antisera in rabbits.  
Bleeds were screened for cross-reactivity with phosphorylated and non-
phosphorylated Cx35 by western blot against in vitro phosphorylated Cx35 
intracellular loop or carboxyl terminal domain fusion proteins (see below for 
methods). 
Bleeds showing significant reactivity against phosphorylated Cx35 
were affinity purified.  To prepare affinity columns, approximately 3 mg of the 
phosphorylated and non-phosphorylated peptides were coupled to Sulfolink 
columns (Pierce) according to the manufacturer’s instructions.  Linking 
efficiencies ranged from 80% for non-phospho-Ser110 to 95% for phospho-
Ser276.  Antibodies were affinity purified by a modification of the method of 
(Tsang and Wilkins, 1991).  25-50 ml of serum were diluted with an equal volume 
of PBS and the following additions were made: 1% phosphatase inhibitor cocktail 
(Sigma), 4 μg/ml aprotinin, 4 μg/ml leupeptin, 10 mM benzamidine, 10 mM NaF, 
and 0.15% Igepal CA-630.  The diluted sera were passed over the phosphopeptide 
columns twice, and the columns washed with 100 ml BBS (1 M NaCl, 100 mM 
boric acid, 20 mM Na borate, 0.1% Tween-20), followed by 6 ml HBS (25 mM 
Hepes, pH 7.4, 0.25 M NaCl, 0.01% NaN3).  The columns were then eluted with 
15 ml EtMg (3 M MgCl2, 25% ethylene glycol, 75 mM Hepes, pH 7.2), followed 
by 6 ml 0.1 M acetic acid, 0.1 M NaCl, 25% ethylene glycol.  The acid eluate was 
immediately neutralized by addition of 1 M Tris base until the pH was >7.  The 
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eluates were combined and dialyzed for 20 hr against PBS plus 0.05% NaN3 and 
0.05% Igepal CA-630.   
Dialyzed, affinity-purified antibodies were passed over the 
corresponding non-phosphopeptide columns twice and the flow-through fractions 
were concentrated using Centriprep centrifugal filtration devices (Millipore, 
Billerica, MA).  Antibodies that bound to the non-phosphopeptide columns were 
washed, eluted, dialyzed, and concentrated as before to obtain “pan-specific” 
antibody fractions.   
 
In vitro phosphorylation 
GST fusion proteins containing the cytoplasmic intracellular loop and 
carboxyl terminal domains of perch Cx35 (Burr et al., 2005; Ouyang et al., 2005) 
were expressed in E. coli strain BL21 and purified by binding to glutathione 
sepharose 4B (Amersham, Piscataway, NJ).  Fusion proteins (0.5 to 1 μg protein 
per reaction) were incubated with 0.5 units cAMP-dependent protein kinase 
(PKA) catalytic subunit (mouse α isoform; New England Biolabs, Beverly, MA) 
for 90 min. at 37°C.  The final solution contained 50 mM Tris-Cl (pH 7.5), 10 
mM MgCl2, 300 μM ATP, 27 mM NaCl, 0.5 mM KCl, 2 mM Na2HPO4, 0.3 mM 
KH2PO4, and 10% glycerol.  The incubation mixtures were dissolved in an equal 
volume of 2x SDS sample buffer, electrophoresed in varying amounts, and blotted 
to nitrocellulose membranes for screening antisera and affinity-purified 
antibodies. 
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Retinal membrane preparations 
Hybrid striped bass (Morone saxatilis/M. americana) were obtained 
from the Texas A&M University Department of Wildlife and Fisheries Sciences 
and were maintained in circulating tanks in the laboratory on a 12hr light:12hr 
dark cycle.  Fish were taken either 2 hr prior to the onset of light (dark-adapted) 
or 2 hr after the onset of light (light-adapted), anesthetized with 0.3% 2-
aminobenzoic acid methyl ester (Sigma), and sacrificed.  Retinas were dissected 
out and homogenized by sonication in ice-cold 0.32 M sucrose, 10 mM Tris-Cl, 
pH 7.2, 2 mM EGTA, 5 mM MgCl2, 1 μM okadaic acid, 1% protease inhibitor 
cocktail (Sigma).  For dark eyes, procedures were performed under dim red 
safelight illumination through the homogenization steps.  The suspension was 
centrifuged for 5 min at 1000 x g to remove large particulates, and then the 
supernatant was centrifuged for 1 hr at 100,000 x g to pellet membranes.  The 
membrane pellet was resuspended in the homogenization medium without 
protease or phosphatase inhibitors.  Protein concentration was measured by the 
BCA technique (Pierce). 
Daytime, light-adapted rabbit eyes were obtained from Dr. Michael 
Mauk (University of Texas Medical School at Houston) from animals sacrificed 
for other experiments.  Retinas were dissected out and membrane preparations 
made as for hybrid bass.  Daytime, light-adapted mouse eyes were obtained from 
Dr. Steven Wang (University of Texas Medical School at Houston) from animals 
sacrificed for other experiments.  Membrane preparations were prepared in a 
similar manner except that high-speed centrifugation was performed in a 
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Beckman airfuge for 30 min at approximately 100,000 x g.  All procedures 
performed on animals were approved by the institutional animal care and use 
committee.   
For each membrane preparation, a portion of the preparation was 
digested with bacterial alkaline phosphatase.  The membrane preparations were 
diluted to 2 mg protein/ml with alkaline phosphatase assay buffer (final buffer 
composition 10 mM Tris-Cl, 10 mM MgCl2, 0.5% Igepal CA-630, plus 15-28% 
of the membrane homogenization buffer), and digested with 17-25 units alkaline 
phosphatase (Fermentas, Hanover, MD) per mg protein for 30 min at 37ºC plus an 
additional 2 hr at 50ºC.  The samples were then diluted to 1 mg protein/ml with 2x 
SDS sample buffer.  Comparable non-digested samples were prepared at the same 
concentration with alkaline phosphatase buffer but no enzyme.   
 
Western blot 
Samples of in vitro phosphorylated fusion proteins or retinal 
membrane preparations were resolved on SDS-PAGE minigels by standard 
procedures.  Proteins were transferred to nitrocellulose (for in vitro 
phosphorylated proteins) or PVDF (for retinal membrane preparations) 
membranes electrophoretically.  For screening crude antisera, portions of the blots 
were incubated with dilutions of crude serum ranging from 1:500 to 1:50,000 in 
TBST (137 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4, 0.1% Tween-20).  
Signals were developed with Cy3-conjugated secondary antibodies (Jackson 
Immunoresearch, West Valley, PA) and viewed with a Typhoon imager (GE 
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Healthcare Bio-Sciences, Piscataway, NJ).  For retinal membrane preparations, 
blots were incubated with affinity purified phospho-specific antibodies diluted to 
1 μg/ml in high-salt TBST (500 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4, 
0.1% Tween-20) plus 2% nonfat dry milk.  Blots were also probed with a 
monoclonal anti-Cx35/36 antibody (Chemicon, Temecula, CA) that was 
developed against the perch Cx35 intracellular loop (O'Brien et al., 2004) at 1 
μg/ml in the same solution.  Blots were developed with peroxidase-linked 
secondary antibodies (Pierce) and detected by chemiluminescence using x-ray 
film.   
 
Immunoprecipitation 
Daytime, light-adapted bass retinal membrane preparations (240 μg 
total protein) were diluted to 400 μl in modified PBST (137 mM NaCl, 3 mM 
KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 2 mM EDTA, 1% Triton X-100, 0.5% Na 
deoxycholate, pH 7.4) with 1% protease inhibitor cocktail (Sigma) and incubated 
with 1 μg mouse anti-Cx36 antibody (Zymed Laboratories, San Francisco, CA) at 
4ºC for 4 hr.  The protein-antibody mixture was further incubated with 20 μl of 
50% slurry of protein G-agarose resin (Amersham) at 4ºC for 1 hr.  This mixture 
was centrifuged for 5 min at 1000 x g and the pellet was washed three times with 
0.5 ml modified PBST and then resuspended in 2x SDS sample buffer for 
electrophoresis.  The IP supernatant and a sample of the initial lysate were 
acetone precipitated to prepare samples for electrophoresis.  Western blot of the 
samples was performed as above with this modification: the ReliaBlot kit (Bethyl 
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Laboratories, Montgomery, TX) was utilized to mask the Ig signal from the 
immunoprecipitation antibody according to the manufacturer’s instruction.  
Briefly, PVDF membrane with transferred protein samples was blocked in 
ReliaBlot blocking reagent and then probed with rabbit anti-phospho-S110 
antibodies (1.6 μg/ml in Reliablot blocking reagent) overnight at 4ºC.  The blot 
was developed with peroxidase-linked secondary antibodies provided in the kit 
and detected by chemiluminescence using x-ray film. 
 
Immunostaining 
Eyecups were prepared from hybrid striped bass either 2 hr before the 
start of the light-cycle under infrared illumination (dark-adapted) or 2 hr after the 
start of the light-cycle under normal room lights (light-adapted).  The eyecups 
were incubated in 2000 units/ml hyaluronidase (Sigma) in PBS for 20 min, and 
then washed twice for 15 min each in PBS.  Subsequently all eyecups were fixed 
for 15 min in fresh 1% N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (Sigma) in fixation buffer (116 mM Tris, 68 mM NaCl, 1.3 mM 
KCl, 52 mM Na2HPO4, 25 mM NaH2PO4, 0.9 mM KH2PO4, pH 7.5), and then 
washed three times for 30 min each in PBS.  Eyecups were cryoprotected 
overnight at 4ºC in PBS plus 30% sucrose, 0.25% NaN3, embedded in Tissue-Tek 
O.C.T. compound (Sakura Finetek, Torrance, CA), and cryosectioned (20 or 40 
μm sections).  Sections were incubated in PBST (PBS plus 0.5% Triton X-100, 
0.1% NaN3) with 10% normal donkey serum (Jackson) for 5 hours to block 
nonspecific binding.  Sections were then incubated with 2 μg/ml mouse anti-
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Cx35/36 (Chemicon) and either rabbit anti-phospho-Ser110 or rabbit anti-
phospho-Ser276 (0.8 or 1 μg/ml, respectively) in PBST with 10% normal donkey 
serum overnight at 4ºC.  Sections were washed three times for 10 min each in 
PBST, and then incubated with Cy3-conjugated donkey anti-mouse IgG (Jackson; 
1:250 dilution) and Alexa 488-conjugated donkey anti-rabbit IgG (Molecular 
Probes, Eugene, OR; 1:250 dilution) for 2.5 hours.  Sections were then washed 
three times for 10 min each in PBST, mounted with Vectashield (Vector 
Laboratories, Burlingame, CA), and imaged on a Zeiss LSM 510 Meta confocal 
microscope using 12-bit data acquisition.  All specimens were imaged using 
similar settings to allow comparison of phospho-antibody labeling in different 
parts of the retina and under different conditions.  Images presented are stacks of 
three confocal slices totaling approximately 1 μm of focal depth.  Image 
processing (Adobe Photoshop; Adobe Systems, San Jose, CA) was limited to 
applying a uniform threshold (approximately 10%) to all images in all color 
channels to reduce background haze.  One low-power overview image was 
brightened (figure 6, phospho-Ser276) to make small gap junction plaques visible.   
 
Quantitative Image Analysis 
Medium-power, high-resolution images that included the entire inner 
plexiform layer were collected for quantitative analysis using identical confocal 
microscope settings.  For each condition 3-6 images were collected from each of 3 
eyecups which were each from different fish.  Images were analyzed with the 
same settings using SimplePCI software (Compix, Sewickley, PA) to 
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automatically select regions of interest (ROIs) from the Cx35 plaques, as 
identified by the mouse anti-Cx35/36 (Chemicon) labeling.  Briefly, regions of 
interest were defined as contiguous pixels with an intensity threshold greater than 
20% of the total intensity range, and which covered a minimum area of 16 pixels 
(~0.1 μm2 or larger).  Each image was then manually scanned for individual ROIs 
that included more than one plaque.  These were eliminated from the analysis.  
Mean fluorescence intensity was measured in each channel (monoclonal Cx35 
labeling; phospho-Cx35 labeling) for each ROI (hereafter called ‘plaques’).  The 
intensity of phospho-Cx35 antibody labeling was then normalized to the intensity 
of the monoclonal Cx35 antibody labeling for each individual plaque.  Cx35 
plaques were separated into two subgroups for further analysis based on readily 
apparent differences between plaques of typical size and “giant plaques” that were 
distributed symmetrically in two bands in the IPL.  Histograms of plaque size 
were generated in Matlab (The MathWorks, Natick, MA) using 250 pixel (~1.225 
μm2) bins.  A cutoff point (1000 pixels, ~4.9 μm2) was empirically determined 
that distinguished the giant plaques apparent upon visual inspection from all other 
plaques.  For each image the mean normalized phospho-Cx35 intensity of each 
population of plaques (“normal” and “giant”) was calculated.  Mean values for 3-
6 images per eyecup were averaged to yield a grand mean normalized phospho-
Cx35 intensity for each population of plaques for each eyecup.  Note that each 
eyecup represents one animal.  Unpaired t-tests were performed to compare 
eyecups across conditions. 
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Results 
Cx35/36 is regulated by phosphorylation at conserved sites 
Connexin 35/36 is the most widespread neuronal gap junction protein 
in the vertebrate central nervous system.  A preponderance of evidence from 
retinal neurons suggests that gap junctional coupling through Cx35/36 can be 
regulated by environmental conditions such as light exposure and by 
neurotransmitter signaling pathways.  Comparable regulation has been observed 
directly for Cx35 in cell culture expression systems and has been shown to 
depend on direct phosphorylation of the connexin (Ouyang et al., 2005; Patel et 
al., 2006).  The outcomes of these studies indicate that two phosphorylation sites 
are critical for regulation of coupling by the cAMP/PKA pathway, and perhaps 
the cGMP/PKG pathway as well.  Figure 1A shows these two sites, Ser110 in the 
intracellular loop and Ser276 in the C-terminal domain (Ser276 in teleost, 
amphibian, and avian Cx35 is equivalent to Ser293 of mammalian Cx36 and 
Ser273 of skate Cx35), and a putative model of regulation by PKA (adapted from 
(Ouyang et al., 2005).  In this model, phosphorylation at both Ser110 and Ser276 
is required to cause substantial uncoupling of Cx35 gap junctions; 
phosphorylation of either residue alone causes only very modest uncoupling 
(Ouyang et al., 2005).  Furthermore, this behavior can be reversed, i.e. 
phosphorylation can lead to increased coupling, under conditions that alter the 
interactions at the tip of the C-terminus.  The molecular details of this “switch” 
are unknown.   
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 Figure 1.  Regulation of Cx35 by phosphorylation. 
A.  Phosphorylation of Cx35 at two sites, Ser110 (on the intracellular loop) and 
Ser276 (on the carboxyl terminus), cause reductions in coupling through Cx35 
gap junctions.  Phosphorylation at both sites has a nearly 3-fold larger effect than 
phosphorylation at either site alone.  This regulation can be reversed by altering as 
yet unknown interactions with the end of the C-terminal domain.  Model adapted 
from (Ouyang et al., 2005).  B.  Alignments of the Cx35/36 sequences 
surrounding the regulatory phosphorylation sites from diverse species.  Both 
regulatory sites are highly conserved.  Cx35/36 contains consensus sequences for 
phosphorylation by several protein kinases in these domains (listed above the 
phosphorylated residues).  Phosphorylation by kinases shown in bold has been 
verified experimentally (Ouyang et al., 2005; Patel et al., 2006; Urschel et al., 
2006).  Amino acid residue numbering is for perch Cx35. 
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Figure 1B shows an alignment of Cx35/36 sequences from several 
species in the regions surrounding these regulatory phosphorylation sites.  
Sequence analysis shows that these regions contain consensus phosphorylation 
sequences for a number of different protein kinases, listed above the sequences.  
Those that have been verified experimentally (all through in vitro studies) are 
shown in bold.  It is apparent that the previously identified regulatory 
phosphorylation sites are highly conserved across widely divergent vertebrate 
species.  Furthermore, these sites are potential targets of several protein kinases, 
which in turn represent several different signaling pathways.  These include 
cAMP-dependent protein kinase (PKA), a terminal effector of the dopamine 
signaling pathways,  and cGMP-dependent protein kinase (PKG), a terminal 
effector of nitric oxide signaling, both of which are important in light adaptation 
in the retina. 
 
Conserved regulatory phosphorylation sites are phosphorylated in the retina 
The convergence of several different signaling pathways on common 
regulatory sites suggests that the phosphorylation status of these sites may be used 
to estimate the functional state of the gap junctions.  To examine this hypothesis 
we developed phospho-specific antibodies against both regulatory sites of Cx35.  
We examined the specificity of these antibodies with western blots against 
bacterially-expressed GST fusion proteins of either the Cx35 intracellular loop 
(IL) domain, containing the Ser110 phosphorylation site, or the carboxyl terminal 
(CT) domain, containing the Ser276 phosphorylation site.  Figure 2A shows a  
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Figure 2.  Specificity of the phospho-Cx35 antibodies.   
Western blot analysis of GST-fusion proteins phosphorylated in vitro with PKA 
using two phospho-specific anti-Cx35 antibodies.  A.  The blot was probed with 
polyclonal anti-Cx35 phospho-Ser110.  The antibody labeled the Cx35 
intracellular loop domain (IL) phosphorylated by PKA (middle lane), but not the 
non-phosphorylated IL domain (left lane).  The IL domain contains the Ser110 
site targeted by this antibody.  The antibody also failed to recognize the 
phosphorylated Cx35 C-terminus (CT; right lane), which contains the Ser276 site.  
B.  The blot was probed with polyclonal anti-Cx35 phospho-Ser276 antibody.  
This antibody labeled the in vitro phosphorylated Cx35 CT (middle lane), but did 
not label the non-phosphorylated CT (left lane).  Phosphorylated Cx35 IL (right 
lane) was not labeled.  Each lane contains 200 ng GST fusion protein. 
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western blot with the phosho-Ser110 antibody.  This antibody reacted strongly to 
the IL domain phosphorylated in vitro with PKA, but showed no measurable 
reaction to the non-phosphorylated IL domain.  Furthermore, this antibody 
showed no cross-reaction with the in vitro phosphorylated Cx35 CT domain.  
Thus the antibody was specific for the phosphorylated form of the protein and did 
not cross-react with the other major PKA phosphorylation site.  Likewise, figure 
2B shows a similar western blot with the phospho-Ser276 antibody.  As with the 
phospho-Ser110 antibody, this antibody was specific for the phosphorylated form 
of the protein and did not cross-react with the Ser110 site. 
If phosphorylation of Cx35 is involved in regulation of coupling in 
retinal neurons, we would predict that both Ser110 and Ser276 sites would be 
phosphorylated to some extent in Cx35 derived from the retina.  To test this 
prediction we performed western blots on membrane preparations from hybrid 
bass retina taken in the dark and light parts of their diurnal cycle.  We treated half 
of each membrane preparation with alkaline phosphatase (AP) to remove 
phosphate groups from the protein.  A monoclonal antibody against Cx35 (figure 
3, panel A) identified Cx35 as a diffuse band running around 30-32 kDa, in 
keeping with previous reports (O'Brien et al., 1998; Pereda et al., 2003; O'Brien et 
al., 2004).  The phospho-Ser110 antibody (panel B) labeled the same band in 
untreated retinal membranes.  The labeling was lost in AP digested membranes.  
Note that this antibody also labeled several high molecular weight bands in retinal 
membranes.  That labeling was also lost upon AP digestion, suggesting that these 
were phosphorylated proteins with PKA phosphorylation sites similar to that of  
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 Figure 3.  Phospho-Cx35 antibodies recognize Cx35 in hybrid bass retinal 
membrane preparations.   
A.  Western blot of membrane preparations from dark-adapted retina (D, left two 
lanes) and light-adapted retina (L, right two lanes).  A monoclonal antibody 
against Cx35 recognized the appropriate band between 30-32 kDa.  Digestion of 
the membranes with alkaline phosphatase (AP; right lane of each pair) had no 
effect on this labeling.  B.  Western blot of retinal membranes probed with the 
phospho-Ser110 antibody.  The phospho-Ser110 antibody recognized the same 
band identified by the monoclonal antibody in preparations from both dark- and 
light-adapted retinas.  Labeling by the phospho-Ser110 antibody was lost in 
membranes digested with AP.  The phospho-Ser110 antibody also recognized 
high molecular weight bands in the blot, but labeling was lost with AP digestion 
indicating that these are phospho-proteins.  C.  Western blot of retinal membranes 
probed with the phospho-Ser276 antibody.  The phospho-Ser276 antibody also 
recognized the Cx35 band in both dark- and light-adapted retinal membranes.  
Labeling by the phospho-Ser276 antibody was lost in membranes digested with 
AP.  Each lane contains 40 μg retinal membrane protein. 
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Cx35’s Ser110 site.  There was little difference in the intensity of phospho-Ser110 
labeling on the Cx35 band between dark and light conditions, nor in the total 
amount of Cx35 between dark and light conditions.  The phospho-Ser276 
antibody also recognized the Cx35 band in retinal membranes (panel C), and this 
labeling was lost upon AP digestion.  No non-specific bands were detected with 
this antibody.  Again, the difference between dark and light conditions was 
minimal.  These results suggest that Cx35 is indeed phosphorylated in bass retina 
at both regulatory sites. 
The regulatory phosphorylation sites of Cx35 are highly conserved 
among diverse vertebrate species (e.g. figure 1B), which suggests that regulation 
by phosphorylation at these two sites is likely also to be conserved.  To test 
whether these sites were phosphorylated in other species we examined retinal 
membranes from two mammals, mouse and rabbit, for phosphorylation of Cx36 
on Ser110 and Ser293 (= Ser276 of teleost Cx35).  Figure 4 shows that both 
phospho-specific antibodies labeled Cx36 in daytime, light-adapted mouse and 
rabbit retinal membranes.  This labeling was destroyed by digestion of the 
membranes with AP.  Although not shown in these blots, labeling of 
phosphorylated high molecular weight bands in mouse and rabbit retina was again 
evident with the phospho-Ser110 antibody. 
Labeling of phospho-proteins other than Cx35 in western blots using 
the phospho-Ser110 antibody raises the question of whether this antibody can be 
used to examine phosphorylation of Cx35 in intact tissues.  It is possible that 
labeling of Cx35 gap junctions by the antibody may represent phosphorylation of  
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 Figure 4.  Phospho-Cx35 antibodies recognize Cx36 in mammalian retinal 
membranes. 
Cx36 was labeled by the Cx35 monoclonal antibody (bottom panel) in western 
blots of membrane preparations from light-adapted mouse (left two lanes) and 
rabbit (right two lanes) retina.  Both the phospho-Ser110 (top panel) antibody and 
the phospho-Ser276 antibody (middle panel) recognized the same band identified 
by the monoclonal antibody in both species.  This labeling was largely lost in 
membranes digested with alkaline phosphatase (AP).  Each lane contains 40 μg 
retinal membrane protein. 
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proteins associated with the Cx35 gap junctions rather than actual 
phosphorylation of Cx35.  To examine this question we performed 
immunoprecipitation experiments with the monoclonal anti-Cx35 antibody and 
probed the precipitates with the phospho-Ser110 antibody.  Figure 5 shows that 
the immunoprecipitate containing phosphorylated Cx35 did not contain any of the 
high molecular weight phospho-proteins found in the original retinal membrane 
preparation.  In contrast, the supernatant from the experiment contained the same 
complement of high molecular weight phospho-proteins as did the crude 
membranes.  This implies that the phosphorylated proteins recognized by the 
phospho-Ser110 antibody are not associated with Cx35 in a complex, and thus are 
not predicted to interfere with analysis of Cx35 gap junctions. 
 
Phosphorylation of Cx35 is controlled at the level of individual gap junctions 
We did not see gross changes in Cx35 phosphorylation between dark 
and light conditions by western blot analysis.  However, it is possible that the 
phosphorylation state, and by inference the coupled state, of Cx35 gap junctions 
may be regulated at the level of individual gap junctions.  To test this hypothesis 
we examined hybrid bass retina by confocal immunofluorescence techniques 
using the two phospho-specific Cx35 antibodies.  Figure 6 shows the pattern of 
labeling by the Cx35 phospho-Ser110 antibody (A-C) and the Cx35 phospho-
Ser276 antibody (D-F) compared to labeling with a Cx35 monoclonal antibody.  
Both phospho-Ser110 (A) and phospho-Ser276 (D) antibodies labeled abundant 
punctate structures in both inner and outer plexiform layers in a pattern similar to  
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 Figure 5.  Phospho-proteins non-specifically recognized by the phospho-
Ser110 antibody are not associated with Cx35. 
Immunoprecipitation of Cx35 from hybrid bass retinal membrane preparations 
using monoclonal anti-Cx35 and probed with anti-phospho-Ser110.  The 
immunoprecipitate lane (IP) contained phosphorylated Cx35 but none of the high 
molecular weight phospho-proteins detected in western blots of retinal 
membranes (lysate lane; see also figure 3B).  In contrast, the IP supernatant 
(super.) contained the same suite of phospho-proteins as found in the lysate.  Each 
lane contains the equivalent of 90 μg retinal membrane protein.   
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that of Cx35 labeling (B and E).  In the merged images it is evident that many 
Cx35 plaques were also labeled for phospho-Ser110 (C) or phospho-Ser276 (F).  
The phospho-Ser110 antibody also showed strong non-specific labeling of Müller 
cells (A and C).  This labeling was much less apparent, though present to some 
extent, in retina from other species (authors’ unpublished observations).  The 
phospho-Ser276 antibody showed only minor non-specific labeling of blood 
vessels in the retina.   
Closer examination of the inner plexiform layer revealed that 
individual gap junctions labeled with the Cx35 monoclonal antibody (figure 7 B 
and C; shown in red) had highly variable labeling for phospho-Ser276 (figure 7 A 
and C; green).  Some Cx35 plaques showed extensive, bright phospho-Ser276 
labeling while others had essentially none (arrow).  One readily identifiable group 
of Cx35 gap junctions were the extremely large (up to 32 μm2) plaques distributed 
in two bands, one each in sublamina a and sublamina b, that we have previously 
reported (O'Brien et al., 2004).  The cell type harboring these gap junctions is 
unknown, although they fit the description of the large gap junctions between 
large-caliber amacrine cell processes identified by (Marc et al., 1988) in TEM 
studies of goldfish retina.  In nighttime, dark-adapted retina these gap junctions 
were highly phosphorylated at Ser276 (figure 7 A and C, triple arrowhead).  
However, in daytime, light-adapted retina there was much less immunostaining 
for phospho-Ser276 on these gap junctions (figure 7 D and F, triple arrowhead).  
At the same time one population of medium-sized Cx35 gap junctions still 
showed substantial phosphorylation on the Ser276 site (single arrowheads), while  
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 Figure 6.  Phospho-Cx35 antibody labeling patterns in hybrid bass retina. 
A.  Labeling pattern of phospho-Ser110 antibody in light-adapted hybrid bass 
retina.  The phospho-Ser110 antibody labeled abundant punctate structures in the 
inner and outer plexiform layers (IPL and OPL, respectively).  It also strongly 
labeled Müller cells, as illustrated here by the bright labeling of their somas above 
the IPL and long trunks descending through the IPL.  Scale bar is 20 μm; scale is 
the same for each image.  B.  Labeling with the monoclonal Cx35 antibody in the 
same section reveals the distribution of Cx35 in the OPL and IPL.  C.  Merged 
image of A and B.  Many of the plaques identified as Cx35 by the monoclonal 
antibody were also labeled by the phospho-Ser110 antibody (co-localization 
shown in yellow).  D.  Labeling pattern of phospho-Ser276 antibody in light-
adapted hybrid bass retina.  The phospho-Ser276 antibody also labeled abundant 
punctate structures in the IPL and OPL.  Minor non-specific labeling resembled 
blood vessels in the retina.  D.  Cx35 monoclonal antibody staining in the same 
section shows a largely overlapping distribution of signals.  F.  Merged image of 
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D and E.  Many of the plaques identified as Cx35 by the monoclonal antibody 
were also labeled by the phospho-Ser276 antibody (co-localization shown in 
yellow). 
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again others had none (arrow).  We could not determine from these data whether 
the medium-sized Cx35 gap junctions, some of which were highly phosphorylated 
and some non-phosphorylated under both dark and light conditions, belonged to 
the same population or to different ones.   
Similar results were observed with the phospho-Ser110 antibody 
(figure 7 G-L).  Again, there was substantially more Ser110 phosphorylation on 
the giant plaques in dark conditions than in the light.  The small to medium sized 
Cx35 gap junctions showed variable levels of phosphorylation in both light and 
dark conditions, with some gap junctions showing no phosphorylation (arrow). 
To determine if the changes in Cx35 phosphorylation that were 
observed empirically represent consistent changes we performed quantitative 
analysis of the phospho-specific antibody labeling on giant Cx35 plaques in the 
inner plexiform layer.  The large size of these giant plaques relative to others in 
the hybrid bass retina, their typical oblong shape, and their unique distribution 
were used to segregate them from the total population of plaques for analysis.  
Figure 8A shows a histogram of the distribution of Cx35 plaques by size in the 
inner plexiform layer.  Plaque abundance decreased steadily with increasing area, 
and the vast majority of plaques were included in bins containing areas less than 
2.5 μm2.  The number of plaques per bin became relatively stable in bins 
containing areas greater than 4.9 μm2, and this was chosen as the cutoff point to 
segregate giant plaques from the total population.  Visual inspection of the image 
data confirmed that all plaques above the cutoff point were of the characteristic 
size, shape, and distribution described above.  Phospho-specific antibody labeling  
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 Figure 7.  Cx35 phosphorylation varies across gap junction type and with 
light-adaptation state. 
All images are from sublamina b of the inner plexiform layer of hybrid bass 
retina.  A-C.  Double labeling for phospho-Ser276 (A) and monoclonal anti-Cx35 
(B) in dark-adapted retina.  Scale bar is 5 μm; scale is the same for each image.  
C.  Merged image of A and B.  Many Cx35 plaques were strongly labeled by the 
phospho-Ser276 antibody in dark-adapted retina, including the giant plaques 
described (triple arrowhead), while other plaques were devoid of labeling (arrow).  
D-F.  Double labeling for phospho-Ser276 (D) and monoclonal anti-Cx35 (E) in 
light-adapted retina.  F.  Merged image of D and E.  Phospho-Ser276 antibody 
labeling was markedly reduced on Cx35 giant plaques in light-adapted retina 
(triple arrowhead), and again some plaques showed no labeling at all (arrow).  A 
population of medium-sized plaques continued to show strong labeling in light-
adapted retina (single arrowheads).  G-I.  Double labeling for phospho-Ser110 (G) 
and monoclonal anti-Cx35 (H) in dark-adapted retina.  I.  Merged image of G and 
H.  Numerous Cx35 plaques were labeled by the phospho-Ser110 antibody in 
dark-adapted retina, including strong labeling on the giant plaques.  J-L.  Double 
labeling for phospho-Ser110 (J) and monoclonal anti-Cx35 (K) in light-adapted 
retina.  L.  Merged image of J and K.  Phospho-Ser110 labeling was reduced on 
Cx35 giant plaques in light-adapted retina.  Labeling on other plaques was 
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variable, with most Cx35 gap junctions showing some labeling.  However, a few 
showed no labeling (arrow).  The descending process of a Müller cell non-
specifically labeled by the phospho-Ser110 antibody can be seen on the right side 
of the image. 
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normalized to the monoclonal Cx35 antibody labeling was calculated for each 
plaque in 3-6 images per animal (see methods).  Figure 8B shows the effect of 
background illumination on Cx35 phosphorylation at Ser110 and Ser276 (n = 3 
animals per condition).  Giant plaques (figure 8B, right two pairs) showed 
significantly less phosphorylation at Ser110 and Ser276 in light-adapted retina 
(unpaired t-test, p < 0.05 for each).  The remaining smaller plaques (figure 8B, 
left two pairs) did not show any significant difference in phosphorylation at either 
Ser110 or Ser276 between dark- and light-adapted retinas. 
 In the outer plexiform layer, where Cx35 is present in both cone and 
bipolar cell gap junctions (O'Brien et al., 2004), the phospho-Ser276 antibody 
labeled several morphologically distinct populations of Cx35 gap junctions 
(figure 9).  Large plaques that varied from round to ellipsoid (arrows), and which 
may represent bipolar cell gap junctions, showed strong phospho-Ser276 labeling 
in both dark- and light-adapted retina.  Narrow, string-like gap junctions (double 
arrowheads), which likely represent those found on cone telodendria (O'Brien et 
al., 2004), were also well-labeled by the phospho-Ser276 antibody in both 
conditions.  Small, round plaques (arrowheads) showed lesser phospho-Ser276 
labeling than the other two populations in the dark-adapted retina and almost no 
labeling in the light-adapted retina. 
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 Figure 8.  Quantitative analysis of phosphorylation on Cx35 plaques in the 
inner plexiform layer. 
A.  Histogram of Cx35 plaque size in the IPL.  The arrow indicates the 
empirically determined cutoff point used to distinguish the giant plaques 
distributed in two symmetric bands in the IPL from the total population of Cx35 
plaques (see methods).  Each bin is 250 pixels (~1.225 μm2).  For visual clarity, 
only every other bin is labeled on the x-axis.  Note that scaling on the y-axis 
switches to logarithmic after the break.  Data from six animals are shown (3-6 
images per animal).  B.  Effects of background illumination on Cx35 gap junction 
phosphorylation.  Giant plaques (right two pairs) exhibited significantly less 
phosphorylation at both Ser110 and Ser276 in light-adapted retina than in dark-
adapted retina.  The remaining smaller plaques (left two pairs) did not show a 
significant difference in phosphorylation at Ser110 or Ser276 between dark- and 
light-adapted retina.  n = 3 animals per condition.  * designates significance at p < 
0.05 level. 
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 Figure 9.  Phosphorylated Cx35 in the outer plexiform layer. 
A-C.  Double labeling for phospho-Ser276 (A) and monoclonal anti-Cx35 (B) in 
dark-adapted OPL.  Scale bar is 5 μm; scale is the same for each image.  C.  
Merged image of A and B.  Large, round-ellipsoid (arrows) and string-like (double 
arrowheads) Cx35 plaques were well-labeled by phospho-Ser276 in dark-adapted 
OPL.  Small, round plaques (arrowheads) showed lesser labeling.  D-F.  Double 
labeling for phospho-Ser276 (D) and monoclonal anti-Cx35 (E) in light-adapted 
OPL.  F.  Merged image of D and E.  Phospho-Ser276 antibody labeling on light-
adapted OPL was similar to dark-adapted OPL for large, round-ellipsoid (arrows) 
and string-like (double arrowheads) Cx35 plaques, while small round plaques 
(arrowheads) showed almost no labeling. 
 
“ 
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Zebrafish are rapidly emerging as a prominent model system for studies of 
the retina and of disease (Fadool and Dowling, 2007; Lieschke and Currie, 2007).  
The phospho-specific Cx35 antibodies also label Cx35 gap junctions in zebrafish in 
confocal light microscopy and in immuno-electron microscopy (Li et al., 2009); John 
Rash, personal communication).  Using these tools we found also found light-
dependent changes in the phosphorylation of Cx35 plaques in zebrafish.  Exposing 
dark-adapted zebrafish eyecups to 15 minutes of photopic light triggered decreases in 
the phosphorylation of a subpopulation of large gap junction plaques at both Ser110 
and Ser276 (figure 10).  Although smaller in absolute size than the very large plaques 
in hybrid bass, these gap junctions are similar in all aspects to those in hybrid bass: 
their large size relative to other Cx35 gap junctions, characteristic oblong 
morphology, and distribution in sublamina 1 and at the border of sublaminae 4 and 5 
in the inner plexiform layer (IPL), and are likely to mediate coupling between the 
same cell type in zebrafish as the giant plaques do in hybrid bass. 
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 Figure 10.  Modulation of Cx35 phosphorylation by acute light exposure in 
zebrafish retina. 
A & C, In dark adapted zebrafish retina, phosphorylation is strong at both Ser110 and 
Ser276 on the population of largest-sized Cx35 plaques.  B & D, 15 minutes of photopic 
light exposure reduced phosphorylation at both Ser110 and Ser276 on the population of 
largest-sized Cx35 plaques.  E, Effects of 15 minutes of photopic light exposure on Cx35 
gap junction phosphorylation in nightime, dark-adapted zebrafish eyecups.  
Phosphorylation on the population of largest-sized Cx35 plaques (right two pairs), 
resembling the “giant” plaques of hybrid bass retina, was significantly reduced at both 
Ser110 and Ser276 by the exposure to bright light.  The remaining smaller plaques (left 
two pairs) did not show a significant difference in phosphorylation at Ser110 or Ser276 
across conditions.  The pattern of change in mean phosphorylation in all groups strongly 
resembles the pattern obtained when comparing dark-adapted and light-adapted hybrid 
bass retina.  n = 5 animals per condition.  * designates significance at p < 0.05 level, ** 
designates significance at p < 0.01 level. 
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“ 
Discussion 
 The regulation of coupling through Cx35/36 gap junctions by 
phosphorylation has now been well described.  (Mitropoulou and Bruzzone, 2003) 
found that a consensus PKA recognition sequence in the intracellular loop of 
perch Cx35 was essential for the 8-Br-cAMP-induced reduction in hemichannel 
currents observed in Xenopus oocytes.  They further found that re-creating this 
recognition sequence in skate Cx35, which was unresponsive to 8-Br-cAMP in its 
wild-type form in Xenopus oocytes, conferred the same behavior to this connexin.  
This strongly suggested that phosphorylation regulates current flow through 
Cx35.  We subsequently showed that phosphorylation by PKA at Ser110, the 
target of this PKA recognition sequence, was responsible for reduction of tracer 
coupling in perch Cx35 expressed in HeLa cells.  However, full regulation 
required concomitant phosphorylation at a second site, Ser276, in addition to 
Ser110 (Ouyang et al., 2005).  Phosphorylation at either site alone caused only a 
small degree of uncoupling: a 20% reduction in diffusion coefficient in mutants 
lacking one phosphorylation site compared to a 56% reduction in diffusion 
coefficient in the wild-type. 
 PKA phosphorylation at the homologous sites has been confirmed for 
mouse Cx36 and parallel regulation by PKA phosphorylation has been proposed 
(Urschel et al., 2006), although direct regulation by phosphorylation was not 
tested.  Nonetheless, the high degree of sequence homology between these 
connexin gene homologues suggests that the mammalian Cx36 is regulated in the 
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same fashion as fish Cx35.  Our finding that both mouse and rabbit Cx36 were 
phosphorylated at both Ser110 and Ser293 (homologous to Ser276 in fish Cx35) 
in the retina supports this contention. 
It is not yet clear how phosphorylation regulates coupling in Cx35/36 
gap junctions.  Phosphorylation could have a direct effect on channel properties of 
Cx35/36 gap junctions, as has been seen for a number of other connexin channels.  
For example, Cx43 channels expressed in SkHep1 cells show a reversible shift 
from a 90-100 pS main state to a 60-70 pS subconductance state with activation of 
PKC (Moreno et al., 1994; Kwak et al., 1995).  These effects are mediated by 
phosphorylation of Ser368 by PKC (Lampe et al., 2000).  Macroscopic coupling 
through Cx45 was also found to be influenced by phosphorylating conditions: 
PKC phosphorylation increased conductance, while PKA or tyrosine 
phosphorylation decreased conductance (van Veen et al., 2000).  However, in this 
case subconductance states were not observed to change; changes in the open 
probability of the channels were responsible for the changes in macroscopic 
conductance.  Thus phosphorylation can affect several important characteristics of 
gap junction channels that influence functional coupling. 
Phosphorylation may also affect assembly or disassembly of gap 
junctions.  Treatment with phorbol esters increased Cx43 phosphorylation and 
inhibited assembly of plasma membrane Cx43 into gap junctions in Novikoff 
hepatoma cells (Lampe, 1994).  This treatment did not appear to influence 
stability of pre-existing gap junctions.  In lens fiber cells, Cx50 and Cx46 were 
phosphorylated and gap junctions partially disassembled by similar phorbol ester 
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treatments (Zampighi et al., 2005).  Such treatments also resulted in a substantial 
decrease in dye coupling, although it is not clear whether the reduction in dye 
coupling is a result of gap junction disassembly or changes in channel properties.  
Studies of Cx36 have revealed that mutation of the major consensus 
phosphorylation sites did not affect trafficking of Cx36 to the plasma membrane 
or the formation of gap junctions (Zoidl et al., 2002).  The latter suggests that 
regulation of Cx35/36 by phosphorylation on the identified regulatory sites is 
more likely due to modification of channel properties than of gap junction 
assembly. 
The requirement for phosphorylation of two separate sites to regulate 
Cx35/36-mediated coupling imparts significant flexibility.  First, these two 
phosphorylation sites have substantially different sequences that may have 
different affinities for PKA or the phosphatases that de-phosphorylate them.  One 
of the sites, Ser276, is also known to overlap with a calmodulin binding site (Burr 
et al., 2005).  Hence the sites can be considered independent.  Second, the two 
identified regulatory phosphorylation sites appear to be targets for a number of 
signaling pathways in addition to the cAMP/PKA pathway.  We have found that 
PKG also phosphorylates both of these sites in vitro (Patel et al., 2006).  These 
sites are also consensus phosphorylation sequences for Casein Kinase II, Ca2+-
Calmodulin-dependent kinases, and S6 Kinase II (summarized in figure 1; see 
also (Sohl et al., 1998; Urschel et al., 2006).  Not all of these kinases are predicted 
to phosphorylate both sites, which emphasizes that the sites are not equivalent.  It 
is possible to construct a number of regulatory schemes that rely on two or more 
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independent signaling pathways to control the coupling through Cx35/36 gap 
junctions.  Two such pathways, the dopamine pathway routed through cAMP and 
the nitric oxide pathway routed through cGMP, are both important in light 
adaptation and known to influence gap junction coupling. 
One significant prediction of the requirement for phosphorylation at 
two sites to regulate coupling is that gap junctions in different cell types could be 
regulated in different ways.  Our phosphorylation data provide evidence that this 
is the case in the fish retina.  The giant Cx35 gap junctions in the IPL showed 
prominent shifts in phosphorylation state at both Ser110 and Ser276 sites between 
dark-adapted and light-adapted conditions.  Our model predicts that the weakly 
phosphorylated state of these gap junctions in the light would correlate with 
strong coupling, while the heavily phosphorylated gap junctions in the dark-
adapted state would support reduced coupling.  However, the changes in 
phosphorylation state seen in the very large gap junctions were clearly not global.  
Many medium sized Cx35 gap junctions in the vicinity of these large plaques 
were well phosphorylated under both dark- and light-adapted conditions, and a 
few were virtually non-phosphorylated under both conditions.  Since we could not 
identify the cell types in which these gap junctions reside, we could not determine 
if they represent relatively invariant gap junctions or rather a shift in 
phosphorylation status between light- and dark-adapted states in particular cell 
populations.  In either case, the presence of strongly and weakly phosphorylated 
gap junctions in close proximity indicates that the phosphorylation state of the gap 
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junction is under local control.  This implies that adjacent neural circuits regulate 
their coupled states independently, even though they use the same connexin. 
The abundant Cx35 gap junctions in fish retina belong to many cell 
types.  Although we have found them to be present in cone photoreceptor and 
Mb1 bipolar cell gap junctions, the majority are likely to be in amacrine cells, as 
revealed by in situ hybridization labeling of many cell types in the proximal inner 
nuclear layer (O'Brien et al., 2004).  Tracer coupling and the ultrastructural 
presence of gap junctions has been described in several types of amacrine cells in 
the fish retina (Teranishi et al., 1984; Marc et al., 1988; Hidaka et al., 1993; 
Teranishi and Negishi, 1994; Hidaka et al., 2005).  These gap junctions allow 
expansion of receptive fields beyond the dendritic spread, spike synchronization, 
and summation of responses (Hidaka et al., 1993; Hidaka et al., 2005).  In 
mammalian AII amacrine cells, homologous coupling provides for summation of 
rod signals, in part setting the sensitivity of the rod pathway.  Regulation of 
coupling preserves the fidelity of rod signaling through the broad scotopic 
operating range (Bloomfield and Volgyi, 2004).  Unlike the very well studied 
mammalian AII amacrine cell, very little has been reported regarding changes in 
fish amacrine cell receptive fields in response to light adaptation. 
The striking change in phosphorylation of Cx35 in the giant gap 
junctions with light adaptation suggests that the cell type harboring these gap 
junctions re-configures its receptive field during adaptation.  Based upon the 
previous results reported in cell culture systems (Ouyang et al., 2005), we predict 
that the decrease in phosphorylation at both Ser110 and Ser276 on giant gap 
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junctions in light-adapted retina will result in increased coupling, which in turn 
may influence receptive field size and signaling range in the cell type harboring 
them.  Note that this change in coupling in response to light-adaptation would be 
opposite to that which is observed in the AII amacrine cell (Bloomfield and Xin, 
1997).  Dopamine signaling is known to increase in light-adapted retina (Kramer, 
1971; Iuvone et al., 1978; Dearry and Burnside, 1986) and to cause uncoupling in 
the AII amacrine cell via D1-type receptors (Hampson et al., 1992).  If dopamine 
also influences the phosphorylation of the Cx35 giant gap junctions we predict 
that it would do so via D2/D4-type dopamine receptors, such as those found in 
photoreceptors (Cohen et al., 1992) and dopaminergic interplexiform cells 
(Harsanyi and Mangel, 1992) and which cause a decrease in cAMP signaling 
through a gi protein.  The nitric oxide/cGMP/PKG pathway has also been shown 
to affect Cx35 phosphorylation, and several other signaling pathways are 
predicted to (Patel et al., 2006).  This raises the possibility that phosphorylation of 
the giant gap junctions is influenced by transmitters other than dopamine.  In the 
absence of physiological data we cannot at present speculate further about the 
consequences of decreased phosphorylation on giant Cx35 gap junctions in hybrid 
bass, but presumably such a change would contribute to optimization of signal 
processing during light adaptation. 
“ 
 
 The modulation of Cx35 phosphorylation in hybrid bass relative to light 
adaptation state could be controlled by light-stimulated changes in cell signaling, but 
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circadian control of phosphorylation cannot be ruled out in these experiments since the 
dark-adapted and light-adapted eyes were collected at different points in the light cycle.  
However, the finding that acute light exposure modulates phosphorylation of Cx35 in 
zebrafish provides evidence that regulation of Cx35 by light is controlled, at least in part, 
by light-stimulated changes in cell signaling.  Circadian control may also exist, though 
future experiments must be done to determine this. 
 Previous research in several fish species has identified a cell type that is likely 
to harbor the large or “giant” Cx35 gap junctions that we found in zebrafish and hybrid 
bass.  In an ultrastructural study of the goldfish retina very large gap junction plaques 
(similar in size to the large plaques in the hybrid bass IPL) were identified in large-
caliber amacrine cell dendrites that stratified in sublayer 1 of the IPL (Marc et al., 1988).  
The cell containing these very large gap junction plaques was inferred to make 
homologous gap junctions with neighboring cells and to possess transient ON-OFF light 
responses based on its similarity to a cell in the retinas of carp and roach fish (Djamgoz et 
al., 1990; Negishi and Teranishi, 1990; Cook and Becker, 1995).  The morphology of this 
cell type has been documented in several fish species (carp, roach, and Japanese dace); it 
has a fusiform soma located in the inner nuclear layer (INL) immediately adjacent to the 
IPL (but is also sometimes reported as being interstitial and located in sublayer 1 of the 
IPL), is bistratified, and makes gap junctions at tip-tip or tip-shank contacts with 
neighboring cells of the same type (Wagner and Wagner, 1988; Djamgoz et al., 1989; 
Hidaka et al., 2005).  This cell’s gap junctions are organized into very large plaques that 
pass neurobiotin but do not pass Lucifer yellow (Hidaka et al., 2005), a characteristic of 
Cx35/36 gap junctions (Hampson et al., 1992).  These studies suggest that the cell type 
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harboring the large or “giant” Cx35 gap junctions is common to all teleost fish species, 
and likely shows modulation of Cx35 phosphorylation by light in the same direction as 
we observed in hybrid bass and zebrafish.  
 
“ 
The diversity of neurotransmitter receptors and signaling pathways in 
retinal neurons allows for vastly different but finely-tuned responses specific to 
individual cell types.  Cx35 gap junctions are a key component of some neural 
circuits and have the potential to remodel circuit properties in response to 
signaling.  The convergence of multiple signaling pathways at regulatory 
phosphorylation sites on Cx35 (see figure 1) implies that the coupling state of 
Cx35-expressing cells can be controlled with a high degree of precision, and our 
results suggest that this happens at a very local level in retinal neurons. 
“ 
 
 Our results also highlight the need for readily identifiable retinal neuron 
networks in future studies of the signaling mechanisms regulating Cx35/36 gap junctions.  
The large number of inner retinal networks that express this protein threaten to “drown 
out” signaling effects that preferentially modulate phosphorylation of Cx35/36 in only 
one or two cell types.  In this study we were able to bypass this difficulty due to the 
unique characteristics of the giant gap junctions.  Future studies may have similar success 
by utilizing genetically-altered mice which express GFP in individual retinal neurons 
(Siegert et al., 2009) that express Cx36, or by utilizing cells types which can be readily 
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and diffusely immunolabeled, such as the mammalian AII amacrine cell (Massey and 
Mills, 1999).  The AII amacrine cell is a particularly promising target for such studies as 
it is already known that dopamine signaling modulates the coupling state of the AII 
network (Hampson et al., 1992). 
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Chapter 3 
 
Dopamine-stimulated dephosphorylation of connexin 36 mediates AII 
amacrine cell uncoupling 
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“ 
Introduction 
 Electrical synapses formed by gap junctions between neurons underlie 
a number of important neural functions, including neuronal synchronization 
(Deans et al., 2001), signal averaging (DeVries et al., 2002), and network 
oscillations (Hormuzdi et al., 2001; Buhl et al., 2003), in addition to providing an 
alternative form of synaptic connection with properties that differ distinctly from 
the more common chemical synapses.  Connexin 36 (Cx36) is the most widely 
expressed gap junction protein in neurons (Connors, 2009), but little is known 
about how intercellular coupling mediated by Cx36 is regulated.  Loss of Cx36 
eliminates electrical coupling and coordinated output in certain cortical 
interneurons (Deans et al., 2001), impairs gamma frequency oscillations in 
hippocampus (Hormuzdi et al., 2001; Buhl et al., 2003), causes deficits in 
cerebellar motor learning (Van Der Giessen et al., 2008), and eliminates the high-
gain rod photoreceptor pathway (Guldenagel et al., 2001; Deans et al., 2002; 
Volgyi et al., 2004).  Cx36 is also the dominant connexin in pancreatic beta cells 
(Serre-Beinier et al., 2008), and loss of these gap junctions causes insulin 
secretion abnormalities that resemble those observed in type 2 diabetes 
(Wellershaus et al., 2008).  Thus, understanding the regulation of Cx36 channel 
function is of critical importance to understanding brain and sensory system 
function as well as endocrine function. 
 The retina is an ideal tissue for studying regulation of gap junction-
mediated coupling; every class of retinal neuron expresses gap junction proteins 
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(Bloomfield and Volgyi, 2009), and the tissue remains physiologically intact 
when isolated from the eye.  In mammalian retina the AII amacrine cell, which 
receives input from rod bipolar cells (Strettoi et al., 1990) and is critical for rod-
mediated vision (Guldenagel et al., 2001; Deans et al., 2002; Volgyi et al., 2004), 
is a well-established model for studying Cx36-mediated coupling (Famiglietti and 
Kolb, 1975; Mills and Massey, 1995; Feigenspan et al., 2001a; Mills et al., 2001b; 
Veruki and Hartveit, 2002a; Xia and Mills, 2004; Veruki et al., 2008).  AII 
amacrine cells are extensively coupled to each other by Cx36 gap junctions under 
scotopic background light and are uncoupled in response to photopic background 
light (Bloomfield et al., 1997; Bloomfield and Volgyi, 2004), dopamine D1-like 
receptor (D1R) activation (Hampson et al., 1992), and protein kinase A (PKA) 
activation (Mills and Massey, 1995; Urschel et al., 2006).  Studies in cell cultures 
have identified two phosphorylation sites on the fish homologue of Cx36, Ser110 
and Ser276 (Ser293 in mammals), that are required for regulation of Cx36-
mediated coupling by PKA (Ouyang et al., 2005).  These sites have been shown 
to undergo dynamic changes in phosphorylation state in the retina (Kothmann et 
al., 2007).  We therefore sought to determine the relationship between Cx36 
phosphorylation and regulation of Cx36-mediated coupling by utilizing the well-
described AII amacrine cell system. 
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Methods 
Intracellular injection 
 Care and use of experimental animals was performed in accordance 
with institutional guidelines at the University of Texas Health Science Center at 
Houston.  All experiments were performed on light-adapted animals in the 
daytime phase of their light cycle.  Adult rabbits were anesthetized with urethane 
(1.5 g/kg, i.p.), and the eyes removed into Ames medium bubbled with 95% 
O2/5% CO2.  Following this, the animals were killed by intracardial injection with 
an overdose of urethane.  The superior portion of the retina was separated into 
several retina-sclera pieces, which were then incubated with DAPI (4,6-diamino-
2-phenylindole; Molecular Probes; Eugene, OR) for 20 minutes to label cell 
nuclei (this short incubation labels AII amacrine cells preferentially (Mills and 
Massey, 1991)).  Immediately before each piece was to be injected, the retina was 
isolated and mounted photoreceptor-side down on black nitrocellulose filters.  
Neurobiotin (3.5%; Vector Laboratories; Burlingame, CA) was injected by 
iontophoresis (±1 nA, 3 Hz) into AII amacrine cells, as described previously in 
detail (Xia and Mills, 2004), except that Alexa 488-conjugated biocytin 
(Molecular Probes) was used to visualize the microelectrode.  Injections were 
performed for 5 minutes on an Olympus BX51WI microscope; this was followed 
by a 15 minute diffusion period.  Each piece was superfused, starting 15 minutes 
prior to the start of the injection and on through the diffusion period, with either 
bubbled Ames medium (at 35°C) or Ames medium containing D1R agonist 
(SKF38393, 10 or 100 μM) or antagonist (SCH23390, 10 or 100 μM).  After 
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tracer injection and diffusion periods, the pieces of retina were fixed for 15 
minutes in 4% formaldehyde in 0.1 M phosphate buffer, and subsequently 
immunolabeled for Cx36 and phospho-Ser293-Cx36 (Kothmann et al., 2007).  
Dopaminergic drugs were purchased from Tocris (Ellisville, MO). 
 
Pharmacology experiments 
 Rabbit eyecups with the vitreous removed were separated into superior 
and inferior portions by chopping along the myelinated band with a razor blade.  
The central portion of the superior part from a single eye was then further 
separated into 4 adjacent retina-sclera pieces.  Each retina-sclera piece was 
incubated for 20 minutes in bubbled Ames medium (at 35°C) with the appropriate 
pharmacologic agent.  Thus, each experiment yielded one control piece and three 
matched pieces subjected to various pharmacological treatments.  Following the 
incubation period, the retina-sclera pieces were fixed for 15 minutes in 4% 
formaldehyde in 0.1 M phosphate buffer, after which the retina was isolated, 
mounted photoreceptor-side down on nitrocellulose filters, and immunolabeled 
for Cx36 and phospho-Ser293-Cx36.  The cAMP analogs were purchased from 
Axxora (San Diego, CA) the microcystin-LR from Calbiochem (San Diego, CA), 
and the tautomycetin from Tocris. 
 
Immunolabeling 
 Isolated retina pieces (photoreceptor-side down on nitrocellulose 
filters) were first blocked overnight at 10°C in immunolabeling buffer (phosphate 
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buffered saline with 0.5% Triton X-100, 0.1% NaN3, pH 7.4) with 10% normal 
donkey serum (Jackson Immunoresearch; West Valley, PA).  Pieces were then 
labeled with monoclonal mouse anti-Cx36 (mCx36, 1:1,000 dilution; Chemicon; 
Temecula, CA) and rabbit anti-phospho-Ser293-Cx36 (Ser293-P, 1:1,000 
dilution) (Kothmann et al., 2007) antibodies in immunolabeling buffer with 10% 
donkey serum for 5 days at 10°C.  Retina pieces from pharmacology experiments 
were also labeled with goat anti-calretinin antibodies (1:5,000 dilution; 
Chemicon) to label AII amacrine cells.  After extensive washing, retina pieces 
were labeled with secondary antibodies (1:500 dilutions) in immunolabeling 
buffer with 5% donkey serum overnight at 10°C.  For retina pieces from injection 
experiments, anti-calretinin labeling was replaced with Alexa 488-conjugated 
streptavidin (1:250 dilution) to label Neurobiotin in the injected network.  Alexa 
488-conjugated streptavidin and secondary antibodies were purchased from 
Molecular Probes.  All other secondary antibodies were Cy3- or Cy5-conjugated 
(Jackson).  Retina pieces were whole-mounted on slides with Vectashield 
(Vector). 
 
Imaging and data quantification 
 Images were collected on a Zeiss LSM 510 Meta confocal microscope 
using a 63x (1.4 N.A.) or 40x (1.3 N.A.) oil immersion objectives.  Imaging 
settings in the LSM software were identical where comparisons are made.  
Coupling between AII amacrine cells was quantified as the diffusion coefficient 
for Neurobiotin tracer transfer using a 2-dimensional compartmental diffusion 
65 
model (Xia and Mills, 2004).  Cx36 phosphorylation was quantified as the ratio of 
the mean intensity of Ser293-P to mCx36 immunofluorescence at individual 
regions of interest (ROIs), each identified by the mCx36 label as a single Cx36 
gap junction plaque.  ROI identification was accomplished using SimplePCI 
software (Compix; Sewickley, PA) to analyze single optical sections.  ROI 
borders were defined by a 20% intensity threshold in the mCx36 channel and a 
size threshold of 0.15 μm2.  For the pharmacology experiments, an additional, 
empirically determined intensity threshold was added in the calretinin channel to 
include only the Cx36 gap junctions localized on the AII network.  In our hands, 
this represents 96% of the Cx36 gap junctions in stratum 5 of the rabbit inner 
plexiform layer, in good agreement with a previously reported value of 98% 
(Mills et al., 2001b).  In the case of injected AII networks, single optical sections 
were collected focused on the distal dendrites of the injected cell, and all gap 
junctions in the field of view were included.  Since 96-98% of the gap junctions at 
this focus depth in the retina are on AIIs, even when Neurobiotin diffusion was 
weak there was a very low probability of including Cx36 plaques that were not on 
AII amacrine cells. 
 In the pharmacology experiments, six images were collected at mid-
peripheral eccentricity from each condition; in the injection experiments, three 
images were collected on different sides of each injected cell.  The ratio of the 
mean intensity of Ser293-P to mCx36 immunofluorescence was calculated for 
each ROI and averaged across all ROIs in all images per condition.  In this way, 
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we collapsed the phosphorylation data into one value per condition per animal in 
order to perform statistical analysis. 
 In order to calculate the fraction of Cx36 plaques that showed any 
detectable phospho-Ser293 antibody labeling, regardless of its intensity, we first 
measured the background labeling in the Ser293-P channel for all images 
(measured in areas where no mCx36 labeling existed).  We then set a threshold 
for detectable labeling at 200% of the mean background value (this value 
approximated the mean + 2 s.d. of the background levels observed in the initial 
experiments).  Any Cx36 gap junction plaque with Ser293-P labeling above this 
threshold was considered “detectably phosphorylated” for purposes of calculating 
the fraction of plaques showing phosphorylation. 
 Images presented in the figures were collected using identical settings 
in the LSM software.  Processing was limited to application of a 10% intensity 
threshold in all channels to minimize background noise. 
 
Statistical analysis 
 A linear regression was used to find the correlation between relative 
Cx36 phosphorylation and AII amacrine cell coupling.  Unpaired, two-tailed t-
tests were used to compare each drug-treated condition with the control condition 
from the same animal.  Unpaired, two-tailed t-tests were also used to compare two 
drug-treated conditions that shared one common drug (such as D1R agonist 
condition vs. D1R agonist plus phosphatase inhibitor). 
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Results 
AII amacrine cell uncoupling is associated with dephosphorylation of Cx36 
 We combined intracellular injection of the Cx36-permeant tracer 
Neurobiotin with immunolabeling for phospho-Ser293-Cx36 in order to measure 
AII amacrine cell coupling and Cx36 phosphorylation in isolated rabbit retina.  As 
previously reported (Hampson et al., 1992), AII-AII coupling was modulated by 
dopamine signaling (Fig.1, A-C).  Activation of D1Rs (SKF38393, 10 μM) 
reduced AII-AII coupling (Fig. 1B), while antagonism of D1Rs (SCH23390, 100 
μM) increased coupling (Fig. 1C).  Phosphorylation of Cx36 at Ser293 (Ser293-P) 
was assessed at gap junctions on the injected AII amacrine cell dendrites and 
those nearby (Fig. 1, D-F; see Methods).  Ser293-P was decreased by D1R 
activation (Fig. 1H) relative to control (Fig. 1G).  Consistent with this, D1R 
antagonism increased Ser293-P (Fig. 1I).  In order to quantify AII amacrine cell 
coupling, we used a compartmental diffusion model to estimate the diffusion 
coefficient of the Neurobiotin tracer (Xia and Mills, 2004).  We quantified 
Ser293-P as a ratio of the mean fluorescence intensity of the phospho-Ser293-
Cx36 antibody to the mean fluorescence intensity of a monoclonal Cx36 antibody 
at each individual gap junction plaque (for full details see Methods section).  We 
collected three images focused on the dendrites of each injected AII amacrine 
cell, calculated the mean Ser293-P for all Cx36 plaques detected across all three 
images, and plotted  this against the diffusion coefficient for Neurobiotin tracer 
transfer measured for that AII amacrine network (Fig. 1J).  A strong correlation 
(r2 = 0.86) was found between AII amacrine cell coupling and Cx36  
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 Figure 1 | AII amacrine cell coupling is directly related to Cx36 
phosphorylation at Ser293.  A-C,  Neurobiotin tracer coupling between AII 
amacrine cells is modulated by dopamine D1R signaling.  D1R activation (B, 
SKF38393, 10 μM) reduced the extent of Neurobiotin diffusion relative to control 
(A).  D1R antagonism (C, SCH23390, 100 μM) increased tracer diffusion.  
Images are mini-stacks (2 μm in z-depth) focused on the somas of the AII 
amacrine cells.  Yellow boxes highlight areas shown in D-I (at different focal 
depth).  D-F,  Cx36 gap junctions, labeled with mCx36 antibody (red) and 
Ser293-P antibody (green), on and around the dendrites of the injected AII 
amacrine cell, labeled with fluorophore-conjugated Streptavidin (blue).  The Cx36 
gap junctions not on the injected cell are primarily on other AII amacrine cells 
(see Methods).  Arrowheads identify prominent Cx36 gap junctions on the 
injected cells.  G-I, Phosphorylation of Cx36 at Ser293, a site known to regulate 
coupling through Cx36 gap junctions (Ouyang et al., 2005), is also modulated by 
dopamine D1R signaling.  Arrowheads identify the locations of the same Cx36 
gap junctions identified in D-F.   D1R activation (H, SKF38393, 10 μM) reduced 
Ser293-P labeling relative to control (G).  D1R antagonism (I, SCH23390, 100 
μM) increased Ser293-P labeling.  J, Quantification of the relationship between 
AII amacrine cell coupling and Cx36 phosphorylation at Ser293.  The mean ratio 
of Ser293-P intensity to mCx36 intensity (across all Cx36 gap junctions in 3 
images per injection) is plotted against the diffusion coefficient for Neurobiotin 
tracer transfer calculated for each injected AII amacrine cell network.  The strong 
correlation of the data (r2 = 0.86) indicates a direct relationship between AII 
amacrine cell coupling and Cx36 phosphorylation at Ser293.  Images are 2 μm-
deep stacks.  Scale bar in C is 50 μm; bar in F is 5 μm. 
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phosphorylation at Ser293.  Since Ser293 is known to regulate coupling through 
Cx36 gap junctions (Ouyang et al., 2005), this finding leads us to conclude that 
phosphorylation at this site increases coupling. 
 
D1R-stimulated dephosphorylation of Cx36 is mediated by PKA 
 The canonical D1R signaling pathway involves a Gs-protein that 
activates adenylyl cyclase, thereby elevating [cAMP]i to activate PKA (Neve et 
al., 2004).  We therefore examined the role of PKA activity in controlling Cx36 
phosphorylation state downstream of D1R signaling using retina-sclera 
preparations (Fig. 2; see Methods).  D1R activation (SKF38393, 100 μM) caused 
a 3.5-fold reduction in Ser293-P intensity (Fig. 2D).  Inhibition of PKA (Rp-8-
CPT-cAMPS, 20 μM) significantly suppressed the effect of D1R activation (Fig. 
2F), resulting in intermediate Cx36 phosphorylation that was below control levels 
but above the levels seen with D1R activation alone.  D1R antagonism 
(SCH23390, 100 μM) caused a 2-fold increase in Cx36 phosphorylation (Fig. 
2H).  As a second measure of the effects of these treatments, we determined if 
they altered the fraction of Cx36 plaques that showed detectable Ser293-P 
labeling, regardless of fluorescence intensity.  Detectable Ser293-P labeling was 
defined as 200% of the background fluorescence in that channel (see Methods); 
this equated approximately to a 5% threshold in the Ser293-P channel.  This 
measure yielded results consistent with the mean Ser293-P measurements (Fig. 
2J).  Histograms of the ratio of Ser293-P to mCx36 fluorescence from one 
representative experiment showed that D1R activation caused a leftward-shift  
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 Figure 2 | PKA mediates D1R-dependent dephosphorylation of Cx36 at 
Ser293 in AII amacrine cells.  A & B,  Under control conditions Ser293-P 
(green) labeling of Cx36 gap junctions (mCx36, red) on AII amacrine cells 
(calretinin, blue) was heterogeneous.  Annotated arrowheads indicate pairs of 
Cx36 plaques along single dendrites that are in different phosphorylation states.  
The close proximity of Cx36 plaques with widely varying Ser293-P labeling 
implies that regulation is locally controlled at individual plaques.  C & D,  D1R 
activation (SKF38393, 100 μM) greatly diminished Ser293-P labeling.  E & F,  
Inhibition of PKA (Rp-8-CPT-cAMPS, 20 μM) attenuated the dramatic reduction 
in Ser293-P labeling caused by SKF38393 (100 μM).  G & H,  Antagonism of 
D1Rs (SCH23390, 100 μM) increased Ser293-P labeling.  I,  Summary of data 
shows that inhibition of PKA significantly suppressed the reduction in Ser293 
phosphorylation caused by D1R activation.  J,  Summary of data shows that 
changes in the percentage of Cx36 plaques that show detectable Ser293-P labeling 
follows the same pattern established for relative Ser293-P measurements in I.  
Error bars are s.e.m, n = 6.  Asterisk denotes P < 0.05, two asterisks denote P < 
0.01.  Images are 1 μm-deep stacks.  Scale bar in H is 10 μm. 
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 Figure S1 | PKA mediates a D1R-stimulated leftward-shift in the relative 
phosphorylation of Cx36 at Ser293 in AII amacrine cells.  A,  Histogram 
displaying the distribution of relative Ser293 phosphorylation (ratio of Ser293-P 
to mCx36 intensity) on Cx36 plaques under control conditions.  Data are from one 
representative experiment displayed in Figure 2.  B,  D1R activation (SKF38393, 
100 μM) caused a leftward-shift in the distribution.  The majority of Cx36 plaques 
showed relatively little or no Ser293 phosphorylation.  C,  PKA inhibition (Rp-8-
CPT-cAMPS, 20 μM) blocked the leftward-shift caused by D1R activation 
(SKF38393, 100 μM).  D,  D1R antagonism (SCH23390, 100 μM) caused a 
strong rightward-shift in the distribution.  Cx36 plaques located in the center of 
the distribution (±1 s.d.) showed relatively strong phosphorylation. 
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(reduction in Ser293-P) in the population of Cx36 plaques which was blocked by 
inhibition of PKA, while D1R antagonism caused a rightward-shift (increase in 
Ser293-P) in the Cx36 population (Fig. S1).  These results lead us to conclude that 
activation of PKA is a component of the pathway regulating Cx36-mediated 
coupling of AII amacrine cells.  However, these results are not consistent with 
direct phosphorylation of Ser293 by PKA, since inhibition of this kinase led to a 
net increase in Cx36 phosphorylation. 
 We also tested the effects of dopamine itself on Cx36 phosphorylation 
at Ser293 in AII amacrine cells.  Consistent with the effects of D1R agonist, 
dopamine application (1 μM) caused a 4-fold reduction in Ser293-P intensity 
(control, mean ratio 0.41 ± 0.06 s.e.m.; dopamine, mean ratio 0.096 ± 0.02 s.e.m.; 
n = 4, p < 0.01), as well as a similar reduction in the percentage of Cx36 plaques 
that showed detectable Ser293-P labeling (control, mean 69 ± 6%; dopamine, 
mean 19 ± 8%; n = 4, p < 0.01) (Fig. S2).  This concentration of dopamine 
represents the upper end of estimates of the physiological extracellular dopamine 
concentration in the vertebrate retina (Witkovsky et al., 1993), and is known to 
strongly uncouple AII amacrine cells (Hampson et al., 1992; Mills and Massey, 
1995).  Thus, endogenous levels of dopamine should be sufficient to drive 
dephosphorylation of Cx36. 
 Modulation of Cx36 phosphorylation at Ser293 could alter coupling 
between AII amacrine cells in several ways.  It could modulate the permeability 
of Cx36 gap junctions to the Neurobiotin tracer, stimulate insertion or removal of 
gap junction proteins from the plasma membrane at each Cx36 plaque, or cause  
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 Figure S2 | Exogenous dopamine application causes dephosphorylation of 
Cx36 at Ser293 in AII amacrine cells.  A, Summary of data shows that 
exogenous application of dopamine (1 μM) caused a strong reduction in the 
intensity of Ser293-P labeling on Cx36 gap junction plaques.  This concentration 
of dopamine represents the upper end of estimates of the physiologic extracellular 
dopamine concentration in the vertebrate retina (Witkovsky et al., 1993), and is 
known to strongly uncouple AII amacrine cells (Hampson et al., 1992; Mills and 
Massey, 1995).  B, Summary of data shows that changes in the percentage of 
Cx36 plaques that show detectable Ser293-P labeling follows the same pattern 
established for relative Ser293-P measurements in A.  Error bars are s.e.m, n = 4.  
Two asterisks denote P < 0.01. 
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 Figure 3 | Phosphorylation of Ser293 on Cx36 does not alter trafficking or 
distribution of the protein.  A,  Conditions that altered Cx36 phosphorylation 
at Ser293 (D1R activation, SKF38393, 100 μM; D1R antagonism, SCH23390, 
100 μM) had no effect on the size of Cx36 plaques in AII amacrine cells.  
Inhibition of PKA (Rp-8-CPT-cAMPS, 20 μM) also had no effect on Cx36 
plaque size.  B,  Conditions that altered Cx36 phosphorylation at Ser293 (D1R 
activation, SKF38393, 100 μM; D1R antagonism, SCH23390, 100 μM) had no 
effect on the overall distribution of Cx36 plaques in AII amacrine cells.  
Inhibition of PKA (Rp-8-CPT-cAMPS, 20 μM) also had no effect on Cx36 
plaque distribution.  Error bars are s.e.m, n = 5.  No significant changes were 
found. 
 
 
 
 
 
 
 
 
 
 
 
 
75 
changes in the number of gap junction plaques between AII amacrine cells.  
Changes in Ser293-P caused by D1R receptor activation (SKF38393, 100 μM) or 
antagonism (SCH23390, 100 μM) had no effect on the mean plaque size of Cx36 
gap junctions or the mean number of plaques on AII dendrites in a given area 
(Fig. 3).  Thus, the changes in tracer coupling between AII amacrine cells 
presented above cannot be attributed to changes in the trafficking of Cx36 
proteins or the number of Cx36 gap junctions connecting AII amacrine cells.  
Rather, it appears that phosphorylation of Ser293 must modulate the permeability 
of Cx36 to the Neurobiotin tracer. 
 
PP2A is required for D1R-stimulated dephosphorylation of Cx36 
 Because D1R activation reduced Ser293-P, we hypothesized that 
dopamine signaling increases overall phosphatase activity at Cx36 gap junctions 
in AII amacrine cells.  In eukaryotic cells protein phosphatase 1 (PP1) and protein 
phosphatase 2A (PP2A) are the most abundant phosphatases (Virshup and 
Shenolikar, 2009); thus, we initially targeted these proteins as potential effectors 
of D1R-stimulated dephosphorylation of Cx36.  We tested the ability of D1R 
agonist to reduce Ser293-P in the presence of different phosphatase inhibitors at 
concentrations that preferentially inhibit either PP1 or PP2A.  Microcystin-LR 
(0.5 nM), an inhibitor with higher affinity for PP2A (IC50 = 40 pM) than for PP1 
(IC50 = 1.7 nM) (Honkanen et al., 1990), completely blocked the reduction of 
Ser293-P caused by D1R activation (SKF38393, 10 μM) (Fig. 4F).  Application 
of microcystin-LR alone significantly increased Ser293-P levels relative to  
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 Figure 4 | PP2A is required for D1R-dependent dephosphorylation of Cx36 
at Ser293 in AII amacrine cells.  A & B,  Control; color scheme and antibodies 
are the same as Figure 2.  C & D,  D1R activation (SKF38393, 10 μM) greatly 
diminished Ser293-P labeling.  E & F,  Inhibition of PP2A (microcystin-LR, 0.5 
nM) completely blocked the reduction in Ser293 phosphorylation caused by D1R 
activation.  G & H,  Inhibition of PP2A alone led to increased phosphorylation of 
Ser293.  I,  Summary of data shows that inhibition of PP2A significantly blocked 
the reduction in Ser293 phosphorylation caused by D1R activation, and that PP2A 
inhibition alone significantly increased Ser293 phosphorylation.  J,  Summary of 
data shows that changes in the percentage of Cx36 plaques that show detectable 
Ser293-P labeling follows the same pattern established for relative Ser293-P 
measurements in I.  Error bars are s.e.m, n = 6.  Asterisk denotes P < 0.05, two 
asterisks denote P < 0.01. Images are 1 μm-deep stacks.  Scale bar in H is 10 μm. 
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control (Fig. 4H), similar to the effect of D1R antagonist application.  Contrasting 
these results, tautomycetin (10 nM), an inhibitor with higher affinity for PP1 (IC50 
= 1.6 nM) than for PP2A (IC50 = 62 nM) (Mitsuhashi et al., 2001), did not prevent 
the D1R-mediated reduction of Ser293-P (Fig. 5F).  Interestingly, inhibition of 
PP1 with tautomycetin in the absence of D1R activation was sufficient to cause a 
robust reduction in Ser293-P (Fig. 5H).  As shown in the previous experiments, 
the percentage of Cx36 plaques showing detectable Ser293-P labeling followed 
the same pattern revealed by measuring the mean Ser293-P for both PP2A and 
PP1 inhibitors (Fig. 4J and 5J).  These results provide a measure of confidence 
that the concentrations of microcystin-LR and tautomycetin used were selective 
for PP2A and PP1, respectively, as only microcystin-LR was able to block the 
effects of D1R activation, and since they had opposite effects on Cx36 
phosphorylation when applied alone.  Together, these experiments argue that 
PP2A is a necessary component of the D1R pathway regulating Cx36 
phosphorylation and coupling strength between AII amacrine cells, and these 
results are consistent with direct dephosphorylation of Ser293 by PP2A.  These 
experiments also provide evidence that PP1 is involved in regulating Cx36-
mediated coupling of AII amacrine cells.  However, these results are not 
consistent with PP1 acting directly on Ser293.  Rather, they indicate that PP1 
negatively regulates the pathway leading to dephosphorylation of Ser293, 
although the exact mechanism for this action is unclear. 
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 Figure 5 | PP1 negatively regulates the dephosphorylation of Cx36.  A & B,  
Control; color scheme and antibodies are the same as Figure 2.  C & D,  D1R 
activation (SKF38393, 10 μM) greatly diminished Ser293-P labeling.  E & F,  
Inhibition of PP1 (tautomycetin, 10 nM) did not alter the effects of D1R 
activation.  G & H,  Inhibition of PP1 alone was sufficient to cause a strong 
reduction in Ser293-P labeling.  I,  Summary of data shows that inhibition of PP1 
did not prevent the reduction in Ser293 phosphorylation caused by D1R 
activation, and that PP1 inhibition alone significantly reduced Ser293 
phosphorylation.  J,  Summary of data shows that changes in the percentage of 
Cx36 plaques that show detectable Ser293-P labeling follows the same pattern 
established for relative Ser293-P measurements in I.  Error bars are s.e.m, n = 4.  
Asterisk denotes P < 0.05, two asterisks denote P < 0.01. Images are 1 μm-deep 
stacks.  Scale bar in H is 10 μm. 
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PKA drives PP2A-mediated dephosphorylation of Cx36 
 Based on the results showing that both PKA and PP2A are 
downstream of D1R activation, we next asked if PP2A itself is activated by PKA 
in AII amacrine cells.  Such a pathway has recently been described in medium-
sized, spiny neurons in the striatum, where D1R-stimulated activation of PKA 
causes phosphorylation of the regulatory subunit of PP2A and thus increases the 
activity of the phosphatase (Ahn et al., 2007).  These striatal neurons bear certain 
similarities to AII amacrine cells (namely, D1R and DARPP-32 expression) 
(Partida et al., 2004; Svenningsson et al., 2004; Witkovsky et al., 2007).  In order 
to test this hypothesis, we bypassed D1Rs and directly stimulated PKA.  PKA 
activation (Sp-8-CPT-cAMPS, 20 μM) strongly reduced mean Ser293-P in AII 
amacrine cells (Fig. 6D), just as D1R activation did.  Inhibition of PP2A 
(microcystin-LR, 0.5 nM) completely blocked the PKA-mediated reduction in 
Ser293-P (Fig. 6F).  Inhibition of PP2A alone caused a trend toward increased 
phosphorylation of Ser293-P (Fig. 6I), similar to the to the significant increase 
noted above (Fig. 4).  As before, the percentage of Cx36 plaques showing 
detectable phospho-antibody labeling followed the same pattern established by 
measuring the mean Ser293-P intensity (Fig. 6J).  These results confirm that 
PP2A is required for PKA-dependent dephosphorylation of Cx36 in AII amacrine 
cells, and support the existence of the D1R → PKA → PP2A pathway in these 
neurons. 
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 Figure 6 | PP2A is required for PKA-dependent dephosphorylation of Cx36 
at Ser293 in AII amacrine cells.  A & B,  Control; color scheme and antibodies 
are the same as Figure 2.  C & D,  PKA activation (Sp-8-CPT-cAMPS, 20 μM) 
greatly diminished Ser293-P labeling, just as D1R activation did.  E & F,  
Inhibition of PP2A (microcystin-LR, 0.5 nM) completely blocked the reduction in 
Ser293 phosphorylation caused by PKA activation.  G & H,  Inhibition of PP2A 
alone slightly increased Ser293 phosphorylation relative to control.  I,  Summary 
of data shows that inhibition of PP2A significantly blocked the reduction in 
Ser293 phosphorylation caused by PKA activation.  We observed a trend towards 
increased Ser293 phosphorylation when PP2A alone was inhibited, similar to the 
significant increase we observed previously with the same treatment (Fig. 4).  J,  
Summary of data shows that changes in the percentage of Cx36 plaques that show 
detectable Ser293-P labeling follows the same pattern established for relative 
Ser293-P measurements in I.  Error bars are s.e.m, n = 5.  Two asterisks denote P 
< 0.01. Images are 1 μm-deep stacks.  Scale bar in H is 10 μm. 
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Phosphorylation of Cx36 is controlled independently at each gap junction 
plaque 
 We frequently observed that Cx36 gap junctions in close proximity of 
each other existed in very different phosphorylation states, even across gap 
junctions positioned along a single dendrite.  This was most apparent in control 
conditions (Fig. 2A & B, arrowheads; also Fig. S1 D).  Pharmacologic activation 
of D1Rs reduced the heterogeneity observed in Ser293-P by causing a strong 
reduction in the relative degree of phosphorylation at each Cx36 plaque.  
Conversely, antagonism of D1Rs led to an increase in the relative degree of 
phosphorylation at each Cx36 plaque, indicating that dopamine-driven 
dephosphorylation of Cx36 is opposed by an unknown process.  Thus, it appears 
that our control condition represents a near-equilibrium point, where conditions at 
some gap junction plaques favor phosphorylation of Cx36 and conditions at 
others favor dephosphorylation of Cx36.  The observation that this variation exists 
even for pairs of Cx36 plaques within a micron of one another suggests that each 
Cx36 gap junction plaque functions as an individual unit, the regulation of which 
is at least partially controlled by very local processes. 
 Overall, we have quantitatively demonstrated the relationship between 
AII amacrine cell uncoupling and Cx36 dephosphorylation.  Our results describe a 
D1R → PKA → PP2A pathway that mediates the dephosphorylation of Cx36 at 
Ser293, and thus the D1R-mediated uncoupling of AII amacrine cells (Fig. 7).  
PP1 activity negatively regulates this dephosphorylation pathway at an unknown 
point.  Our results indicate regulation is likely controlled at the level of individual  
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 Figure 7 | Model of D1R-dependent regulation of Cx36-mediated coupling 
between AII amacrine cells.  Activation of D1Rs (1) initiates a cascade leading 
to activation of PKA (2); both D1R and PKA activation are sufficient to uncouple 
AII amacrine cells (Hampson et al., 1992; Mills and Massey, 1995).  In this study 
we showed that D1R-dependent dephosphorylation (grey P’s) of Ser293 on Cx36 
uncouples AII amacrine cells (3).  We show that PP2A is required for both D1R- 
and PKA-stimulated dephosphorylation of Ser293 (4).  This provides evidence 
that the D1R → PKA → PP2A pathway, which was recently described in spiny 
neurons in the striatum and led to dephosphorylation of Thr75 on DARPP-32 
(Ahn et al., 2007), is also present in the AII amacrine cell.  AII amacrine cells also 
express DARPP-32 (Partida et al., 2004; Witkovsky et al., 2007), and 
dephosphorylation of Thr75 on DARPP-32 facilitates PKA-mediated 
phosphorylation (black P’s) of Thr34 (5), which converts DAPRR-32 into an 
inhibitor of PP1 (6) (Svenningsson et al., 2004).  We found that PP1 negatively 
regulates the dephosphorylation of Cx36, possibly by opposing PKA-mediated 
activation of PP2A (7).  Our results indicate that the D1R → PKA → PP2A 
pathway is not limited to striatal neurons, and may represent a common pathway 
in neurons expressing D1Rs and DARPP-32. 
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Cx36 plaques, and that phosphorylation of Ser293 appears to influence 
permeability of these gap junctions, but not the trafficking of Cx36. 
 
Discussion 
 One fundamental function of the retina is to adapt to fluctuating 
background illumination.  Electrical coupling between AII amacrine cells 
increases the signal to noise ratio of their response to light (Vardi and Smith, 
1996; Dunn et al., 2006).  Modulation of coupling strength between AII amacrine 
cells serves to optimize signal to noise ratio for prevailing background 
illumination, and is one mechanism the retina uses to accomplish luminance 
adaptation (Bloomfield and Volgyi, 2004).  In darkness AIIs are relatively 
uncoupled, thus preserving single-photon responses in a small group of AIIs.  
Coupling increases greatly under low scotopic to mesopic illumination, allowing 
for summation of coincident signals and improved signal to noise ratio.  The AII 
network is uncoupled under photopic illumination by dopamine signaling.  This 
may act to prevent contamination of cone photoreceptor signals in cone bipolar 
cells by saturated rod signals in AII amacrine cells.  In addition, AIIs provide 
inhibitory glycinergic input to Off cone bipolar cells (Strettoi et al., 1992) and 
some Off ganglion cells (Manookin et al., 2008; Murphy and Rieke, 2008; Munch 
et al., 2009).  Thus uncoupling of the AII network should also act to increase the 
spatial resolution of On cone bipolar cell-driven feed-forward inhibition of Off 
cone bipolar and retinal ganglion cells. 
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 Previously it was unclear what molecular mechanism modulates 
coupling through Cx36 gap junctions.  Although increased phosphorylation of 
Cx36 has been implicated as a mechanism for uncoupling gap junctions based on 
the dependence on PKA activity (Ouyang et al., 2005; Urschel et al., 2006), this 
has not been directly assessed.  By making quantitative measures of tracer 
diffusion between AII amacrine cells and the relative phosphorylation of Cx36 
gap junctions between these cells, we have determined that dephosphorylation of 
Ser293 is associated with uncoupling of the AII amacrine cell network.  
Decreases in both coupling and phosphorylation are triggered by dopamine D1R 
signaling and are mediated (at least in part) by activation of PKA.  This finding, 
together with the previous finding that the Ser293 phosphorylation site is one of 
two that are required for regulation of Cx36 coupling by PKA activity (Ouyang et 
al., 2005), provides strong evidence that dephosphorylation of Cx36 at Ser293 is 
the mechanism by which Cx36 gap junctions are uncoupled. 
 It has been reported that SCH23390 (10 μM) blocks the uncoupling 
effect of exogenous dopamine (100 nM) application (Hampson et al., 1992).  It is 
thus curious that in our hands 10 μM SCH23390 did not alter AII amacrine cell 
coupling, but 100 μM SCH23390 increased coupling.  However, technical 
differences between our tracer coupling measurements and those made in the 
previous study preclude direct comparison.  Hampson et al. (1992) used a more 
sensitive but nonlinear (peroxidise amplification) tracer detection method and 3 to 
4-fold longer diffusion periods, potentially amplifying small effects.  It is difficult 
to precisely identify the reason that a high concentration of SCH23390 was 
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required to increase coupling in our experiments.  It is possible that the non-
specific binding of the drug to other targets with low-affinity binding sites 
(Leonard et al., 2006; Ekelund et al., 2007) caused network effects that led to 
increased AII amacrine cell coupling.  However, given that both the D1R agonist 
SKF38393 (10 μM) and dopamine (1 μM) effectively drove reductions in AII 
amacrine cell coupling, the specific action of SCH23390 on D1-like dopamine 
receptors seems most likely. 
 The molecular mechanism by which phosphorylation of Ser293 alters 
coupling through Cx36 gap junctions is still a topic for further study.  We have 
excluded changes in the trafficking of Cx36 proteins and reduction in the absolute 
number of Cx36 gap junctions on AII amacrine cells as potential mechanisms by 
which dephosphorylation of Cx36 reduces coupling.  Thus, it seems likely that 
dephosphorylation of Cx36 reduces its permeability to the Neurobiotin tracer.  
The question of what dephosphorylation of Cx36 does to the single-channel 
conductance and/or open probability or open duration of the channel is of more 
biological significance in neurons.  Although our experiments here cannot directly 
address this measure of channel function, it has recently been shown that the 
junctional conductance between pairs of AII amacrine cells can change 
dynamically up to six-fold (Veruki et al., 2008).  This increase was time-
dependent and was observed with low-resistance patch pipettes, but not with high-
resistance pipettes, leading the authors to suggest that the increase in coupling 
was due to gradual washout of an endogenous regulatory system in the AII 
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amacrine cell.  Washout of cAMP is the most prominent initial candidate, and 
should result in a gradual increase in the phosphorylation of Cx36. 
 Our results indicate that the D1R- and PKA-dependent 
dephosphorylation of Cx36 in AII amacrine cells requires PP2A activation.  A 
D1R → PKA → PP2A pathway also exists in medium-sized spiny neurons of the 
striatum, in which Thr75 of dopamine- and cyclic-AMP-regulated phosphoprotein 
(DARPP-32) is one substrate for PP2A (Ahn et al., 2007).  This 
dephosphorylation allows PKA to phosphorylate Thr34 of DARPP-32, thereby 
converting it into a potent inhibitor of PP1 (Svenningsson et al., 2004).  DARPP-
32 is also expressed by AII amacrine cells (Partida et al., 2004; Witkovsky et al., 
2007), and we show that while PP1 inhibition does not mediate D1R-stimulated 
dephosphorylation of Cx36, PP1 inhibition alone is sufficient to cause Ser293 
dephosphorylation.  As PKA activation of PP2A in the striatal spiny neuron was 
caused by phosphorylation of the regulatory subunit of PP2A (Ahn et al., 2007), 
one explanation for our finding is that PP1 activity may oppose PKA-dependent 
activation of PP2A by phosphorylation (Fig. 7), although we did not explicitly test 
this hypothesis.  It is clear from our results that the dopamine D1R → PKA → 
PP2A pathway is not limited to the striatal neurons where it was first described, 
but is also a component of dopamine signaling in other neurons, such as the AII 
amacrine cell. 
 In the retina, dopamine signaling originates from dopaminergic 
amacrine cells and is associated with light adaptation (Witkovsky, 2004).  In 
addition to the AII amacrine cell, dopamine modulates the coupling state of other 
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Cx36-coupled retinal neurons, such as cone photoreceptors (Lee et al., 2003; 
O'Brien et al., 2004; Zhang and Wu, 2004; Ribelayga et al., 2008) and OFF α 
ganglion cells (Hidaka et al., 2002; Mills et al., 2007).  In both of these cases, 
however, activation of D2-like dopamine receptors triggers the uncoupling.  This 
suggests that in cones and OFF α ganglion cells, reduced [cAMP]i and reduced 
PKA activity mediate uncoupling.  Based on the relationship between Cx36 
phosphorylation and AII amacrine coupling strength that we describe here, we 
would predict that in cones and OFF α ganglion cells PKA acts directly on Cx36 
proteins, rather than activating a phosphatase effector, and in cones this appears to 
be the case (H. Li, A. Chuang, & J.O., 2009; manuscript submitted for 
publication).  Previous reports support this possibility, as we and others have 
shown that PKA can directly phosphorylate regulatory residues on Cx36 in vitro 
(Ouyang et al., 2005; Urschel et al., 2006; Kothmann et al., 2007).  Thus, 
regulation of Cx36-mediated coupling is specific to individual neuronal subtypes 
in the retina and is dependent on the signaling pathways they express. 
 The specificity of regulation that we observe in retinal neurons 
indicates that the signaling pathways that control coupling are likely to vary in 
other Cx36-coupled networks, such as those found in cortex, hippocampus, 
cerebellum and inferior olive, and elsewhere.  For instance, several kinases 
converge onto the regulatory phosphorylation sites of Cx36 in vitro, including 
PKA, PKG, and CamKII (Ouyang et al., 2005; Patel et al., 2006; Urschel et al., 
2006; Kothmann et al., 2007; Alev et al., 2008), suggesting that many common 
signaling pathways can modulate coupling.  The importance of regulation of 
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Cx36-mediated coupling in other networks is currently not well understood, as 
most studies have focused on the consequences of complete loss of Cx36-
mediated coupling (Deans et al., 2001; Buhl et al., 2003; Van Der Giessen et al., 
2008).  The results we present here provide a framework for future study of 
coupling in these systems, where increased phosphorylation of Ser293 indicates 
increased coupling, and vice versa. 
 We commonly observed heterogeneity of Cx36 phosphorylation 
within individual AII amacrine cells under control conditions.  This observation 
implies that Cx36 phosphorylation, and thus coupling, is controlled at the level of 
individual gap junction plaques.  This possibility evokes comparisons to the 
postsynaptic density found at chemical synapses, where complexes of signaling 
proteins are assembled and provide synapse-specific modulation of important 
synaptic elements, such as glutamate receptors (Soderling and Derkach, 2000; 
Feng and Zhang, 2009).  The C-terminal tail of Cx36 binds PDZ domain-
containing proteins (Li et al., 2004), and may bind some of the same molecules 
that form the scaffolding complex at the postsynaptic density.  Additionally, 
CamKII can bind directly to Cx36 (Alev et al., 2008), providing the means for 
localization of one potential regulator of coupling. 
 Local control of coupling would allow for the possibility of activity-
dependent regulation of individual electrical synapses.  This is particularly 
interesting to consider in the case of the AII amacrine cell, which shifts from 
uncoupled in dark-adapted retina to well-coupled through most of the scotopic 
range of vision, and which finally becomes uncoupled again under photopic visual 
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conditions (Bloomfield and Volgyi, 2004) as a result of dopamine signaling.  
What causes the increase in coupling when background illumination increases 
from darkness to scotopic levels?  One possibility is that glutamate release from 
rod bipolar cells causes Ca++ influx in the AII dendrites, leading to activation of 
CamKII and phosphorylation of Cx36, thus increasing coupling in a manner 
dependent on presynaptic activity.  There are several potential sources of Ca++ on 
AII dendrites, including Ca++-permeable AMPA receptors and NMDA receptors 
(Hartveit and Veruki, 1997; Morkve et al., 2002).  One possible role for locally 
increasing coupling in an activity-dependent manner is to allow the spread and 
summation of signals from active rod bipolar cells in AII amacrine cells when 
photon catch is very low (near visual threshold).   Gap junctions not in the vicinity 
of an active rod bipolar cell would remain uncoupled, and thus reduce the sharing 
of noisy fluctuations in the AII membrane potential.  This could be particularly 
important in AIIs, which are inherently noisy due to the nature of the rod bipolar 
to AII amacrine synaptic inputs (Dunn et al., 2006).  As background light 
intensity increases in the scotopic range, additional rod bipolar cells will become 
active, and continue to increase AII amacrine cell coupling, as has been described 
(Bloomfield and Volgyi, 2004). 
“ 
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Chapter 4 
 
Presynaptic activity and NMDA receptor activation drive 
phosphorylation of connexin 36 on AII amacrine cells 
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Figures 1-3 in this chapter represent experiments performed by Brady Trexler, Ph.D., a 
former postdoc with Steve Massey, Ph.D. (Figures 1 and 3), or by Wei Li, Ph.D., a 
former student with Steve Massey, Ph.D. (Figure 2).  Their unpublished observations 
(represented in these figures) stimulated me to develop and test the hypotheses 
concerning the role of NMDA receptors in regulating Cx36 gap junctions on AII 
amacrine cells.  Thus, I have included them here for logical continuity.  I am indebted to 
them for their contributions to this research. 
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Introduction 
 One requirement for a well-functioning sensory system is the ability to adapt 
to fluctuations in prevailing environmental conditions.  For instance, in the course of one 
day the retina must maintain its ability to reliably encode the visual environment and 
transmit this code to the brain, despite the fact that the mean level of background 
luminance will shift over 109-fold from night to day (Rodieck, 1998; Rieke and Rudd, 
2009).  Adaptation serves to maintain appropriate dynamic range of signaling, preventing 
saturation yet preserving discrimination of relevant differences, thus optimizing sensory 
system function.  A hallmark of luminance adaptation in the retina is modulation of the 
strength of electrical coupling between horizontal and amacrine cell interneuron networks 
(Bloomfield et al., 1997; Xin and Bloomfield, 1999; Bloomfield and Volgyi, 2004).  
Modulation of coupling strength in these networks alters receptive field size, and 
consequently changes the spatial extent of feedback and feedforward inhibition.  In the 
AII amacrine cell interneuron network, electrical coupling also improves the signal-to-
noise ratio of the light response (Vardi and Smith, 1996; Dunn et al., 2006). 
 The AII amacrine cell is an obligatory component of the high-sensitivity rod 
photoreceptor pathway (Guldenagel et al., 2001; Deans et al., 2002; Volgyi et al., 2004), 
and is extensively coupled to neighboring AIIs by connexin 36 (Cx36) gap junctions 
(Kolb and Famiglietti, 1974; Famiglietti and Kolb, 1975; Vaney, 1991; Feigenspan et al., 
2001a; Mills et al., 2001b; Veruki and Hartveit, 2002a).  AII amacrine cells display a 
complex inverted U-shaped pattern of electrical and tracer coupling modulation relative 
to increasing background illumination (Bloomfield et al., 1997; Bloomfield and Volgyi, 
2004).  In well dark-adapted retina, the AII network is relatively uncoupled.  When 
93 
background illumination is increased to just above rod photoreceptor threshold, coupling 
increases dramatically, and continues to increase modestly with increasing illumination 
through the rod photoreceptor-dominated range of vision.  If background illumination is 
increased further, into the cone photoreceptor-dominated range of vision, coupling is 
driven back down towards baseline levels.  This reduction of coupling is thought to occur 
through increased dopamine signaling (Hampson et al., 1992; Witkovsky, 2004).  Recent 
work has demonstrated a direct relationship between the phosphorylation state of Cx36 
and tracer coupling in the AII network, and shown that dephosphorylation of the protein 
mediates the uncoupling caused by dopamine signaling (Kothmann et al., 2009).  
However, the mechanism responsible for increasing coupling in the AII network in the 
rod-dominated visual range is still unclear.   
 The observation that AII amacrine cells increase their coupling once 
background illumination exceeds rod photoreceptor threshold, and that coupling 
continues to increase with increasing illumination, suggests an activity-dependent process 
driven by the ON pathways in retinal circuitry.  AII amacrine cells express functional 
NMDA receptors (Hartveit and Veruki, 1997; Zhou and Dacheux, 2004), which 
commonly mediate activity-dependent changes in postsynaptic neurons.  However, to 
date no study has described a physiological role for these receptors in the AII.  In this 
study, we sought to determine if the NMDA receptors expressed by AII amacrine cells 
contribute to processes that increase phosphorylation of Cx36 gap junctions, and thus 
drive increased coupling in the AII network. 
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Methods 
Electrophysiology 
The inferior portions of rabbit eyecups were cut into strips and attached to 
filter paper, vitreal side down.  The sclera and choroid were removed and the retinas were 
bathed in a modified Ames medium (see below).  Retinas were then stored at 10°C for 
later recording.  Slices were cut on a vertical slicer to varying thickness (120 – 200 μm) 
and transferred to the recording chamber. Experiments measuring light responses were 
performed on retinas from rabbits that were dark adapted for 2 hrs prior to enucleation; 
surgery, isolation of the retina, and preparation of slices were done under dim red light.   
 A modified Ames solution was used for storing retinas, bath perfusion of 
slices, and puffer application of drugs.  The salts common to all external solutions 
consisted of (in mM) 115 NaCl, 3.1 KCl, 1.24 MgCl2, 2 CaCl2, 0.1 BaCl2, 6 glucose, 2 
succinate, 1 malate, and 1 lactate.  For the storage solution, 10 mM HEPES, 12 mM 
NaHCO3, and 1 mM pyruvate were added and pH was adjusted to 7.4 with NaOH.  For 
bath perfusion, 24 mM NaHCO3 and 1 mM pyruvate were added and the solution was 
bubbled with 95% O2/5% CO2.  The perfusate was heated to 37°C with an inline heater 
(Warner Instruments, Hamden, CT).  Drugs were diluted from stock solutions into the 
external solution buffered with 20 mM HEPES, pH = 7.4.   
Patch pipette filling solution consisted of (in mM) 110 potassium gluconate, 
10 CsCl, 10 NaCl, 10 HEPES, 10 EGTA, 2 MgCl2, 5 K+ATP, 0.5 Na+GTP.  The pH was 
adjusted to 7.2 with KOH.  Lucifer yellow (0.5 mg/ml) or 0.1 mM Alexa-488 (Molecular 
Probes, Eugene, OR) were included in the patch solutions to confirm cell identity by 
epifluorescent visualization after recording.  All chemicals and pharmacological agents 
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were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.  Drug 
solutions were delivered by single or triple barrel puffer pipettes.  A single barrel would 
contain two or more drugs for testing the effects of simultaneous application, rather than 
perfusion from multiple barrels. 
 Patch electrodes were pulled on a Flaming-Brown horizontal puller from 
Sutter Instruments (Novato, CA) and fire polished on a Narishige MF-83 microforge 
(East Meadow, NY) to a resistance of 7 to 10 MΩ  (in KCl pipette solutions, pipette 
resistances were 5 to 7 MΩ, due to the higher mobility of chloride relative to gluconate).  
Seals in the cell attached configuration ranged from 8 to 20 gigaohms.  Upon obtaining a 
whole cell patch, series resistance was estimated from the peak of the capacitive 
transients due to a square wave voltage pulse and ranged from 20 to 30 MΩ.   Series 
resistance was not compensated but was monitored periodically by the method of 
capacitive transients.  Cell currents and voltages were amplified by Axopatch 200 B 
patch clamp amplifiers (Axon Instruments, Foster City, CA) in resistive feedback mode.  
Current and voltage signals were filtered on [?] the amplifiers at 2 kHz and sampled at 10 
kHz using a PCI-MIO16XE-10 data acquisition board from National Instruments (Austin, 
TX).  Custom software was used for data acquisition and analysis.  
 
Light Stimuli 
 Light responses were recorded from slices visualized using infrared 
photomicroscopy with DIC optics.  Light stimuli were delivered to the slice through the 
objective from a source consisting of 20 LEDs (525 nm peak, ±17 nm at half-width).  The 
LEDs were mounted facing into a plastic sphere, which acted as a diffuser and provided a 
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uniform field of illumination.  The LEDs were driven by digital counter/timers on the 
data acquisition board, and light intensity was varied by pulse width modulation of a 1 
kHz square wave as well as neutral density filters moved into the light path.  Maximum 
output was 5 x 105 photons μm-2 s-1, measured at the focal plane of the slice using an IL-
1700 radiometer (International Light, Newburyport, MA) and apertures of 100 or 400 μm 
(Lenox Laser, Glen Arm, MD).. 
 
Pharmacology experiments 
 Rabbit retina-sclera preparations were made and pharmacology experiments 
performed as described in Chapter 3, except as described below.  For dark-adapted 
experiments, the whole superior portion of the eyecup was stored in bubbled Ames at 
room temperature inside a light-tight chamber for a minimum of 100 minutes.  The light-
tight chamber consisted of two nested cardboard boxes wrapped in dual layers of 
aluminum foil.  A rubber tube carrying the O2/CO2 mix was threaded through a small, 
hole in the outer box, which was then covered with foil.  Secondary silicone tubes fed 
into the inner box and bubbled the Ames medium.  The light-tight chamber was then kept 
in a dark room for the duration of the adaptation.  After the adaptation period, the eyecup 
was cut into four pieces as described in Chapter 3, except that this was performed under 
infrared illumination.  Once separated, the pieces were incubated with pharmacologic 
agents in bubbled Ames back inside the light-tight chamber 
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Immunolabeling 
 Immunolabeling was performed as described in Chapter 3.  Additional 
antibodies used were rabbit anti-NR1 (1;100 dilution; Chemicon) and mouse monoclonal 
antibodies against PKCα (1:500 dilution; Transduction Laboratories, Lexington, KY) and 
kinesin II (1:100 dilution, Convance, Richmond, CA). 
 
Imaging and data quantification 
 Images presented in Figures 2 and 3 were acquired on a Zeiss LSM-410 
confocal microscope with a 63x objective (1.4 N.A.).  Alignment for all three channels 
and resolution were checked at x8 zoom using 1μm fluorescent spheres (Molecular 
Probes, Eugene, OR).  The average distribution of synaptic structures around NMDAR 
clusters was obtained by clipping sections of the image centered on NMDARs, aligning 
these frames and signal averaging for all three channels.  Results were displayed as 
surface plots using custom software.  This is a method to analyze the average distribution 
of labeling in the other two channels around a repeated neuronal structure.  In this paper, 
it was used as a method to assess the average distribution of synaptic ribbons, rod bipolar 
terminals, and Cx36 plaques around NMDAR clusters.  
 All other confocal images were collected on a Zeiss LSM 510 Meta confocal 
microscope using a 63x (1.4 N.A.) objective.  Imaging settings in the LSM software were 
identical where comparisons are made.  Cx36 phosphorylation was quantified as the ratio 
of the mean intensity of Ser293-P to mCx36 immunofluorescence at individual regions of 
interest (ROIs), each identified by the mCx36 label as a single Cx36 gap junction plaque.  
ROI identification was performed as described in Chapter 3. 
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 Five-six images were collected at mid-peripheral eccentricity from each 
condition in the pharmacology experiments.  The ratio of the mean intensity of Ser293-P 
to mCx36 immunofluorescence was calculated for each ROI and averaged across all 
ROIs in all images per condition.  In this way, we collapsed the phosphorylation data into 
one value per condition per animal in order to perform statistical analysis. 
 Images presented in the figures were collected using identical settings in the 
LSM software.  Processing was limited to application of a 10% intensity threshold in all 
channels to minimize background noise. 
 
Statistical analysis 
 Unpaired, two-tailed t-tests were used to compare each drug-treated condition 
with the control condition from the same animal.  Unpaired, two-tailed t-tests were also 
used to compare two drug-treated conditions that shared one common drug (such as D1R 
agonist condition vs. D1R agonist plus phosphatase inhibitor). 
 
Results 
NMDA receptors do not contribute to the light response of AII amacrine cells 
 Much work has been done to characterize the glutamate-driven ionic currents 
present in AII amacrine cells (Hartveit and Veruki, 1997); (Morkve et al., 2002); (Veruki 
et al., 2003; Zhou and Dacheux, 2004), but at present it is unclear if the NMDA receptors 
on these cells play a role in the response to light.  We began this study by reproducing the 
NMDA-mediated currents previously characterized by others (Hartveit and Veruki, 1997; 
Zhou and Dacheux, 2004).  AII amacrine cells were identified for recording in retinal  
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 Figure 1 | NMDA currents in AII amacrine cells do not contribute to the light 
response. 
A) Image of an AII amacrine cell targeted for recording under DIC illumination;  B) 
Lucifer yellow fluorescence in the cell confirms its identity after recording;  C) Puffs of 
NMDA (500 μM, black bars) in the presence of 4 μM Co2+, 1 μM glycine, 2 μM 
strychnine, and 2 μM TTX elicit an outward current in an AII amacrine held at +60 mV;  
D) Current responses in an AII held at +60 mV in response to depolarization of a 
presynaptic rod bipolar cell.  The outward current elicited was almost entirely blocked by 
NBQX (20 μM), an AMPA & kainate receptor antagonist.  Averaging of 5 recorded pairs 
(inset D’) revealed a low amplitude, slow onset current that suggests activation of 
extrasynaptic NMDA receptors;  E) A 500 ms dim light flash (1 R* rod-1 s-1, black bar) 
elicited a 20 mV depoloarization followed by a slight hyperpolarization after light off.  
Application of CPP (20 μM), an NMDA receptor antagonist, did not alter the amplitude 
or waveform of the light response, indicating that NMDA receptors do not influence light 
evoked responses in AII amacrine cells. 
 
 
 
100 
slices by their distinctive small somas and stout primary dendrites that descend through 
the inner plexiform layer (IPL) (Figure 1A).  Patch pipettes contained fluorescent dyes 
for visualization of the cells after recording.  Cell identity was confirmed by the existence 
of characteristic lobular appendages in sublaminae 2 and 3 of the IPL in addition to fine 
dendritic arbors in sublaminae 4 and 5 (Figure 1B).  Puffs of NMDA (500 μM) were 
applied to the dendritic arbor via puffer pipette.  The Ames medium bath was 
supplemented with the coagonist glycine (1 μM), Co2+ (4 mM) to block polysynaptic 
effects, strychnine (2 μM) to block activation of glycine receptors, and TTX (2 μM) to 
block voltage-gated sodium channels on AIIs.  At a holding potential of +60 mV AIIs 
responded to NMDA puffs with an outward current (Figure 1C).  Currents were also 
recorded using a ramp protocol that varied the membrane potential of the cell from -60 to 
+60 mV in the presence of NMDA.  This was repeated with the addition of the NMDA 
receptor antagonist CPP (20 μM).  Subtraction of the NMDA + CPP current from the 
NMDA current alone yielded a J-shaped I-V curve that reversed close to 0 mV 
(Supplemental Figure 1), characteristic of NMDA receptors (Dingledine et al., 1999).  
These results were consistent across 5 recorded AIIs. 
 At synapses where AMPA and NMDA receptors colocalize in the 
postsynaptic membrane, both receptor types contribute to evoked and spontaneous 
EPSCs (Bekkers and Stevens, 1989).  Current evidence suggests that spontaneous EPSCs 
in AII amacrine cells are mediated solely by AMPA receptors (Veruki et al., 2003), 
indicating that NMDA receptors on AIIs may be extrasynaptic.  We directly tested 
whether evoked glutamate release from rod bipolar cells could activate EPSCs in AII 
amacrine cells when AMPA receptors were blocked.  To do this we performed dual  
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 Figure S1 | I-V relationship of NMDA activated conductance on AII amacrine cells. 
Shown is an example of the current-voltage relationship of the NMDA activated 
conductance (shown in Figure 1).  With 4 μM Co2+, 1 μM glycine, 2 μM strychnine and 1 
μM TTX in all perfused solutions, the AII was ramped from -60 to +60 mV.  Currents 
were recorded and averaged in response to 20 voltage ramps.  Shown is the difference 
current between ramps with NMDA and those with NMDA + CPP, an NMDA receptor 
antagonist.  Subtraction of the NMDA+CPP current from the current in NMDA alone 
yielded a characteristic J-shaped I-V curve that reversed at 0 mV. 
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whole-cell patch clamp experiments on rod bipolar cell-AII amacrine cell pairs with and 
without the selective AMPA/Kainate antagonist NBQX in the bath.  In order to maximize 
the possibility of detecting small NMDA-mediated EPSCs, the postsynaptic AII was held 
at +60 mV to alleviate the Mg2+ block of NMDA receptors, and the Ames medium was 
supplemented as above, with the exception that Co2+ was not included.  Rod bipolar cells 
were held at -70 mV and stepped to -30 mV, evoking large, fast inward currents in 
postsynaptic AIIs (Figure 1D).  These were virtually eliminated when NBQX (20 μM) 
was included in the bath, and recovered upon washout of the drug, as expected if AMPA 
receptors alone are located at the synapse.  Similar results were observed in a total of 5 
recorded pairs.  However, when the currents from all rod bipolar-AII pairs were 
averaged, a small, slow inward current was revealed (Figure 1D’).  Such low-amplitude, 
long-latency currents are characteristic of extrasynaptic NMDA receptors (citations).  
This current cannot be explained by electrical input due to spikes in neighboring AIIs, as 
TTX (2 μM) was co-applied with NBQX.  While it is clear that the majority of rod 
bipolar cell input to AIIs is mediated by AMPA receptors, this residual current suggests 
that glutamate released from rod bipolar cells may also bind to putative extrasynaptic 
NMDA receptors on AII amacrine cells. 
 We next asked whether the NMDA receptors on AII amacrine cells contribute 
to the light response of these neurons by flashing dim light on dark adapted retinal slices 
while recording from AIIs in current clamp.  It is known that glutamate spillover occurs 
at the rod bipolar-AII synapse, as stimulating release of glutamate from one rod bipolar 
elicits a glutamate transporter-coupled anion current in neighboring rod bipolar cells 
(Veruki et al., 2006).  We therefore sought to activate the majority of rod bipolar cells in  
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 Figure 2 | NMDA receptors on AII amacrine cells are extrasynaptic. 
A) and A’) High magnification images show the location of NMDA receptors, labeled by 
antibodies against the NR1 subunit (green), on AII amacrine cell dendrites, labeled by 
calretinin antibodies (blue).  Arrows indicate the locations of several NR1 puncta.  B) and 
B’) Rod bipolar cell terminals, labeled by antibodes against PKCα (red), associated with 
the same AII dendrites.  The arrows indicating the positions of the NR1 puncta show that 
NMDA receptors on AIIs are not associated with rod bipolar cell inputs to the AII 
dendrites.  C) and C’) As described in A, but from a different piece of tissue.  D) and D’) 
Labeling of synaptic ribbons by kinesin II antibodies (red) in bipolar cell terminals; the 
arrows indicating the positions of the NR1 puncta show that NMDA receptors on AIIs are 
not associated with sites of glutamate release.  For contrast, compare with the association 
of kinesin II labeling and AMPA receptors on AII dendrites (Li et al., 2002).  Scale bar in 
B’ is 5 μm. 
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the slice in hopes of maximizing the chances of spillover glutamate binding to putative 
extrasynaptic NMDA receptors.  To accomplish this we chose a light flash intensity of 1 
R* rod-1 s-1, which will activate multiple rod bipolar cells presynaptic to each AII 
amacrine cell.  We found that the AII response to a 500 ms light flash was unaffected by 
CPP (20 μM) (Figure 1E), indicating that NMDA receptors do not contribute to the AII’s 
light response even when it receives input from multiple rod bipolar cells.  This is 
perhaps unsurprising given the very large ratio of AMPA to non-AMPA current 
stimulated by glutamate release from a single rod bipolar cell (Figure 1D).  As this 
experiment’s results did not support a traditional role for the NMDA currents in AII 
amacrine cells (i.e. contribution to the light response), we next performed several 
immunolabeling experiments to localize the NMDA receptors on AIIs.  The rationale for 
this was that the anatomical location of the receptors might hint at their function in AII 
physiology. 
 
NMDA receptors on AII amacrine cells are extrasynaptic 
 NMDA receptors are heterotetramers composed of two NR1 subunits and two 
NR2 subunits; NR2 subunits are further divided in four types, A-D, all of which are 
expressed in the retina (Grunder et al., 2000).  Whole mount retinas were labeled with 
polyclonal antibodies against the NR1 subunit in order to label the maximum number of 
NMDA receptors at once for our localization of NMDA receptors on AII amacrine cells.  
AII amacrine cells were labeled diffusely with antibodies against the Ca2+-binding 
protein calretinin (Massey and Mills, 1999).  Finally, we included antibodies against 
PKCα or kinesin II to label rod bipolar cells or synaptic ribbons in presynaptic bipolar  
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 Figure S2 | Spatial fluorescence intensity averages show that NMDA receptors on 
AIIs are not associated with rod bipolar terminals or presynaptic ribbons. 
A)  Signal averaging analysis shows a random pattern of PKC immunoreactivity in 
relation to NR1 puncta associated with AIIs.  There is no central peak in the PKC plot 
corresponding to the two central peaks in the NR1 and calretinin plots.  Instead, the PKC 
plot is flat indicating no association with NR1 or calretinin.  B)  Signal averaging analysis 
shows a random pattern of kinesin II immunoreactivity in relation to NR1 puncta 
associated with AIIs.  There is no central peak in the kinesin II plot corresponding to the 
two central peaks in the NR1 and calretinin plots.  In fact, the kinesin II plot is flat, 
indicating that nearly total absence of label in the sampling boxes.  The size of the 
sampling squares used in the analysis was 2 μm, indicating that ribbons and NR1 puncta 
were not consistently found within 1 μm of each other.   
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cells, respectively.  NR1 labeling was localized on the fine dendrites of AII amacrine 
cells in sublamina b of the IPL (Figure 2, A & C).  AIIs were nearly devoid of NR1 
labeling in sublamina a, where the lobular dendrites of the AII ramify (data not shown).  
Arrows in Figure 2 were placed to indicate the location of NR1 labeling associated with 
AII amacrine cell dendrites.  Examination of rod bipolar cell labeling (Figure 2B) showed 
that most NMDA receptors on the AII dendrites are not closely apposed to rod bipolar 
cell terminals.  Further investigation of the synaptic ribbon labeling (Figure 2D) revealed 
that most NMDA receptors on AIIs were not closely apposed to sites of glutamate release 
from any nearby bipolar cells.  Since the kinesin II labels synaptic ribbons in both rod 
and cone bipolar cells, it appears that the NMDA receptors on AIIs do not receive direct 
synaptic input at all.  This interpretation is reinforced when contrasted against a similar 
immunolabeling experiment showing close association of kinesin II-labeled ribbons and 
synaptic AMPA receptors on AII amacrine cells (Li et al., 2002). 
 To further analyze the relationship between NR1 puncta and rod bipolar cell 
terminals or synaptic ribbons, square sampling boxes (2 μm per side) were placed 
centered on NR1 puncta located on AII dendrites (see Methods).  The spatial intensity 
distributions of fluorescence for each antibody was calculated and then averaged across 
all sampling boxes (Supplemental Figure 2).  The flatness of the PKC and kinesin II 
channel averages indicates that there was no reliable relationship between NR1 labeling 
on AII dendrites and presynaptic rod bipolar cells or glutamate release sites in nearby 
bipolar cells.  All together, this evidence further argues that NMDA receptors on AII 
amacrine cells are localized extrasynaptically. 
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 Figure 3 | NMDA receptors colocalize with Cx36 gap junctions on AII amacrine 
cells. 
A) Triple labeling shows AII amacrine cells labeled by calretinin antibodies (blue), Cx36 
gap junctions (red), and NMDA receptors labeled with NR1 antibodies (green).  White 
spots indicate the colocalization of all strong signals in all three channels.  B) Arrows 
indicate the locations of selected Cx36 gap junctions.  C) The arrows showing the 
locations of Cx36 gap junctions show that NR1 puncta are colocalized with most Cx36 
gap junctions on the AII network.  Scale bar in A is 10 μm. 
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NMDA receptors on AII amacrine cells colocalize with Cx36 gap junctions 
 Although NMDA receptors do not appear to participate in the light response 
of AII amacrine cells in the rod-photoreceptor operating range (Figure 1E), we showed 
that blockade of AMPA receptors on AIIs revealed a small residual current (Figure 1D’).  
This residual current resembled the profile for extrasynaptic NMDA receptors in that it 
was small, had a long latency to onset, and did not appear to inactivate.  It remains 
possible that glutamate spillover might activate very small currents mediated by 
extrasynaptic NMDA receptors in the AII amacrine cell that minimally influence the 
voltage response of the cell to light, but which cause significant Ca2+ influx in a very 
local domains.  Both NMDA receptor activation and Ca2+ influx are required for activity-
dependent potentiation of Cx35-mediated electrical coupling at the mixed 
electrical/chemical synapses in goldfish Mauthner cells (Yang et al., 1990; Pereda and 
Faber, 1996) (Cx35 is the non-mammalian ortholog of mammalian Cx36).  Since 
increasing background illumination increases coupling between AII amacrine cells 
throughout the rod-photoreceptor operating range (Bloomfield et al., 1997; Bloomfield 
and Volgyi, 2004), we investigated whether NMDA receptors were localized near Cx36 
gap junctions on AIIs, and thus in a position to influence gap junctional coupling in the 
AII network.  Whole mount retinas were labeled with antibodies against calretinin, the 
NR1 subunit of NMDA receptors, and Cx36 gap junctions (Figure 3A).  Nearly all Cx36 
gap junctions on AII amacrine cell dendrites were colocalized or closely associated with 
NR1 puncta (Figure 3B).  Arrows in Figure 3 indicate locations on AII dendrites where 
Cx36 gap junctions colocalize with strong NR1 puncta.  As before, we analyzed the 
spatial intensity distribution of fluorescence for each antibody channel, with each square  
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 Figure S3 | Spatial fluorescence intensity averages show that Cx36 gap junctions are 
associated with NMDA receptors on AII amacrine cells. 
A)  Signal averaging of 228 Cx36 plaques from a larger area of retina that included the 
area shown in Figure 3 was used to analyze the association between Cx36 and NR1.  5.4 
μm sampling boxes were placed around Cx36 plaques on AII dendrites.  The NR1 signal 
was hidden to avoid bias.  No distinction was made between plaques at AII dendritic 
crossings and plaques on single dendrites.  The existence of 3 distinct peaks from all 
three signals indicates that the three structures are repeatedly associated.  Loss of a 
central peak upon rotation of the NDMAR1 channel 90 degrees demonstrates that the 
association of NR1 and Cx36 did not occur by chance. B) For comparison, sampling 
boxes were placed around NR1 clusters on AIIs while the Cx36 signal was hidden.  With 
this sampling constraint, again all three signals have a correlated central peak, indicating 
that Cx36 and NR1 indeed that NMDA receptors on AII amacrine cells are very regularly 
associated with Cx36. 
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sampling box centered on Cx36 gap junctions on AIIs (Supplemental Figure 3A).  The 
central peak seen in all three channel averages indicates the association of all three 
signals.  NMDA receptors are expressed by a number of retinal neurons with dendrites 
near to those of AII amacrine cells, such as ON retinal ganglion cells (Zhang and 
Diamond, 2006; Kalbaugh et al., 2009), and much of the NR1 labeling seen is not on AII 
amacrine cells.  The association of Cx36 gap junctions with NR1 puncta was not due to 
chance colocalization of the more numerous NR1 puncta, however, as 90° rotation of the 
NR1 channel relative to the other two channels abolished the associated central peak in 
the spatial average.  As an independent measure we also examined the spatial average 
centered around the NR1 puncta.  The resulting central peak in the Cx36 channel 
indicates a strong tendency for NR1 puncta at this level of the retina to colocalize with 
Cx36 gap junctions (Supplemental Figure 3B).  Thus, NMDA receptors are appropriately 
localized to influence the coupling state of the AII amacrine network by modulating 
Cx36 gap junctions. 
 
Blockade of NMDA receptors and inhibition of CamKII reduce phosphorylation of 
Cx36 on AII amacrine cells 
 In order to test the functional significance of NMDA receptor colocalization 
with Cx36 gap junctions, we used an experimental paradigm we previously established to 
assess the coupling state of Cx36 gap junctions by examining the relative 
phosphorylation state of Cx36 at Ser293 (Cx36-P) (Kothmann et al., 2009).  Using this 
paradigm, we found that increased phosphorylation of Cx36 at Ser293, a site that 
regulates coupling through these gap junctions (Ouyang et al., 2005), is strongly  
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 Figure 4 | Blockade of NMDA receptors and inhibition of CamKII reduce 
phosphorylation of Cx36 gap junctions on AII amacrine cells. 
A) – A”) Phosphorylation of Cx36 at Ser293 is heterogeneous in light-adapted retina.  B) 
– B”) Blockade of NMDA receptors (CPP, 10 μM) reduces phosphorylation of Cx36 at 
Ser293.  C) – C”) Blockade of AMPA/kainate (NBQX, 10 μM) and NMDA receptors 
has little additional effect over blockade of NMDA receptors alone.  D) – D”) Inhibition 
of CamKII (KN-93, 10 μM) reduced phosphorylation of Cx36 at Ser293.  E) Summary of 
experiments (n = 4) shows that blockade of NMDA receptors significantly reduces mean 
phosphorylation of Cx36 on AII amacrine cells.  Additional blockade of AMPA receptors 
does not significantly increase the magnitude of this effect.  Inhibition of CamKII reduces 
phosphorylation of Cx36 to a similar extent as NMDA receptor blockade.  F) The 
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experiments summarized in E were repeated with antagonist of dopamine D1 receptors 
(SCH23390, 50 μM) in the bath (n = 6).  As shown previously, antagonism of D1 
receptors increased mean phosphorylation of Cx36 on AIIs.  It did not prevent the effects 
of NMDA receptor blockade or CamKII inhibition, indicating that both of the effects are 
independent of dopaminergic input to AII amacrine cells.  Analysis was performed on 
single optical sections; images presented are 1 μm-deep z-stacks.  Error bars are SEM, * 
p < 0.05, ** p < 0.01.  Scale bar in D is 10 μm. 
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associated with increased coupling in the AII amacrine cell network.  For the current 
experiments the superior portion of a light-adapted rabbit eyecup was cut into four retina-
sclera pieces with a razor blade.  These were incubated for 20 minutes in control Ames or 
Ames with glutamate receptor antagonist(s) added, and changes in phosphorylation were 
measured using an antibody specific for phospho-Ser293-Cx36 (Kothmann et al., 2007).  
Cx36-P was quantified as the average ratio of phospho-Ser293-Cx36 antibody 
fluorescence to monoclonal Cx36 antibody fluorescence at each individual gap junction 
plaque (for full details on Cx36-P quantification, see Methods).  Phosphorylation of Cx36 
plaques on AII amacrine cells is heterogeneous in light adapted retina (Figure 4A).  
Application of the NMDA receptor antagonist CPP (10 μM) reduced mean Cx36-P by 
2.5-fold (Figure 4B, E), indicating that activation of NMDA receptors in light-adapted 
retina acts to increase phosphorylation of Cx36.  Co-application of the AMPA receptor 
antagonist NBQX (10 μM) with CPP caused a slightly more robust reduction in Cx36-P, 
though not significantly different from CPP alone (Figure 4C, E). 
 Dopamine is a well-known regulator of coupling in the AII amacrine cell 
network (Hampson et al., 1992), with increased dopamine signaling causing reduced 
Cx36-P and reduced coupling (Kothmann et al., 2009).  We tested whether the effect of 
NMDA receptor blockade on Cx36-P was due to modulation of neurons influencing 
dopamine release in the retina by repeating the experiment with the dopamine D1 
receptor antagonist SCH23390 (50 μM) in the bath.  D1 receptor blockade alone 
increased Cx36-P, as we reported previously (Kothmann et al., 2009), but it did not 
prevent the reduction in Cx36-P caused by CPP (Figure 4F).  As before, inclusion of 
NBQX in the bath had no additional effect.  Thus, blockade of NMDA receptors is  
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Figure 5 | Activated CamKII “hotspots” colocalize with Cx36 gap junctions on AII 
amacrine cell dendrites. 
A) A single optical confocal section showing that activated CamKII, identified by 
antibodies against phospho-Thr286-CamKII (green) is widely distributed throughout the 
inner plexiform layer (IPL) of light-adapted retina.  Strong labeling is seen in a ring 
around the soma of a calretinin-labeled AII amacrine cell (red) in the inner nuclear layer 
(INL), as well as in its stout primary dendrite (yellow).  B) A 6 μm-deep z-stack of the 
calretinin label showing more fully the primary dendrite of the AII descending through 
the IPL and branching into fine dendrites.  C) A single optical confocal section showing 
only the activated CamKII label.  D) – D’”) High magnification views of the area 
enclosed in the white rectangle in A.  These single optical confocal sections show cross-
sections through several of the fine dendrites of the AII amacrine cell (D’), and the Cx36 
gap junctions (blue) on them (D”).  Several of the Cx36 gap junctions are indicated by 
arrowheads, and when the activated CamKII label is viewed in isolation (D’”), it is 
evident that several of these Cx36 gap junctions are colocalized with “hotspots” of 
activated CamKII.  Scale bars in A and B are 5 μm, scale bar in D is 2 μm. 
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sufficient to reduce phosphorylation of Cx36 in AII amacrine cells in light adapted retina, 
and is not due to modulation of the dopaminergic pathway which also regulates Cx36-P 
in AIIs. 
 In addition to requiring NMDA receptor activation and Ca2+ influx, the 
activity-dependent potentiation of Cx35-mediated electrical coupling in Mauthner cells 
also requires CamKII activation (Pereda et al., 1998).  We therefore also tested if 
inhibition of CamKII influenced the phosphorylation state of Cx36 gap junctions on AII 
amacrine cells.  Application of the CamKII inhibitor KN-93 (10 μM) reduced mean 
Cx36-P to a similar extent as blockade of NMDA receptors (Figure 4D, E).  As was the 
case with NMDA receptor blockade, the reduction in Cx36-P caused by KN-93 persisted 
with dopamine D1 receptor antagonist in the bath (Figure 4F), indicating that CamKII 
inhibition reduces Cx36-P independent of dopamine signaling.  These experiments 
indicate that in light-adapted retina, activation of NMDA receptors and CamKII activity 
are both required to maintain phosphorylation of Cx36 at Ser293. 
 
Activated CamKII colocalizes with Cx36 gap junctions in AII amacrine cells 
 CamKII is a common mediator of activity-dependent plasticity in neurons 
(Colbran and Brown, 2004).  In order to maintain specificity of targeting, CamKII is 
localized in postsynaptic density found at glutamatergic synapses.  CamKII binds to 
multiple subunits of the NMDA receptor as well as to Cx36 gap junctions, and this 
binding is often facilitated by or requires autophosphorylation of the kinase at Thr286 
(Colbran, 2004; Alev et al., 2008).  We utilized antibodies against phospho-Thr286-
CamKII, calretinin, and Cx36 to determine if the activated kinase is localized near Cx36  
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 Figure 6 | Activation of NMDA receptors drives phosphorylation of Cx36 gap 
junctions on AII amacrine cells. 
A) and A’) Dark adaptation of the retina for 2 hours greatly reduced phosphorylation of 
Cx36 gap junctions at Ser293.  B) and B’) Application of NMDA (50 μM) drove 
increased phosphorylation of Cx36 at Ser293.  C) and C’) Addition of AMPA (5 μM) 
and NMDA drove increased phosphorylation of Cx36 at Ser293 more strongly than 
NMDA did alone.  D) and D’) Interestingly, application of AMPA alone also drove 
increased phosphorylation of Cx36 at Ser293.  E) Summary of experiments (n = 6) shows 
that addition of NMDA to the bath drove phosphorylation of Cx36 back to control, light 
adapted levels (compare with Figure 4E).  Application of AMPA drove increased 
phosphorylation as much as NMDA did.  Addition of AMPA and NMDA drove 
phosphorylation significantly higher than NMDA or AMPA alone.  Analysis was 
performed on single optical sections; images presented are 1 μm-deep z-stacks.  Error 
bars are SEM, ** p < 0.01.  Scale bar in D is 10 μm. 
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gap junctions in AII amacrine cells.  In vertical sections from light-adapted retina there 
was strong phospho-Thr286-CamKII labeling throughout the IPL (Figure 5).  The somas 
of a number of cells were ringed with phospho-Thr286-CamKII labeling, including many 
AII amacrine cells.  Activated CamKII labeling was often strong in the primary dendrites 
of AIIs as well.  Close inspection of the fine dendrites of AIIs in sublamina b of the IPL 
showed that hotspots of phospho-Thr286-CamKII labeling were often colocalized with 
Cx36 gap junctions on the AII network.  These results indicate that activated CamKII is 
appropriately localized to influence the phosphorylation state of Cx36 gap junctions on 
AII amacrine cells, either by direct phosphorylation of the protein of by modulation of 
other proteins regulating phosphorylation of Cx36. 
 
NMDA and AMPA drive phosphorylation of Cx36 on AII amacrine cells 
 We next asked whether activation of NMDA receptors could drive increased 
phosphorylation of Cx36 gap junctions.  For these experiments we began by dark-
adapting the superior portion of a rabbit eyecup for 100 minutes.  The purpose for this 
was twofold.  First, AII amacrine cells in well dark-adapted retinas have been shown to 
be relatively uncoupled (Bloomfield et al., 1997; Bloomfield and Volgyi, 2004).  Thus 
we wished to investigate the phosphorylation state of Cx36 in AIIs after our retina-sclera 
preparations were dark-adapted.  Second, as rod bipolar cells are ON-type bipolar cells 
and release glutamate in response to light, using dark-adapted retinas allowed us to 
examine the effects of NMDA application on relatively quiescent AII amacrine cells.  
After the initial dark-adaptation period, the eyecup was removed from the light-tight 
chamber under infrared illumination and cut into four retina-sclera pieces with a razor  
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 Figure 7 | Activation of ON-bipolar cells by CPPG or background light increment 
drive increased phosphorylation of Cx36 gap junctions on AII amacrine cells. 
A) and A’) Dark adaptation of the retina for 2 hours greatly reduced phosphorylation of 
Cx36 gap junctions at Ser293.  B) and B’) Depolarization of ON-type bipolar cells in 
darkness via antagonism of mGluR6 receptors (CPPG, 200 μM) drove increased 
phosphorylation of Cx36 at Ser293.  C) and C’) Exposure of dark-adapted retinas to 
photopic full-field background illumination also drove increased phosphorylation of 
Cx36 at Ser293.  D) and D’) The effect of increased background illumination was 
abolished when activation of ON-type bipolar cells was inhibited (L-AP4, 50 μM).  E) 
Summary of experiments (n = 5) shows that activation of ON-type bipolar cells drove 
phosphorylation of Cx36 back to control, light adapted levels (compare with Figure 4E).  
Exposure of dark-adapted retinas to photopic background illumination drove 
phosphorylation to a similar extent as ON-type bipolar cell activation did.  Activation of 
mGluR6 receptors on ON-type bipolar cells completely prevented the effects of increased 
background illumination, and actually reduced phosphorylation below control, dark-
adapted levels (but compare with dark-adapted levels in Figure 5E).  Analysis was 
performed on single optical sections; images presented are 1 μm-deep z-stacks.  Error 
bars are SEM, ** p < 0.01.  Scale bar in D is 10 μm. 
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blade.  Pieces were separated into control Ames or Ames with glutamate agonist(s) added 
and placed back into the light-tight chamber for 20 additional minutes, after which 
phosphorylation of Cx36 was measured as before.  Dark-adapting the retina for 120 
minutes led to a dramatic reduction in Cx36-P (Figure 6A), in good agreement with the 
previous reports that AIIs are uncoupled in well dark-adapted retinas (Bloomfield et al., 
1997; Bloomfield and Volgyi, 2004).  Mean Cx36-P in dark-adapted retina was 
approximately 10-fold less than typical values obtained from in light-adapted retinas 
(Figure 4E).  Addition of NMDA (50 μM) to the bath increased Cx36-P back to typical 
light-adapted levels (Figure 6B), indicating that NMDA receptor activation drives 
phosphorylation of Cx36.  Addition of both AMPA (5 μM) and NMDA (50 μM) to the 
bath increased Cx36-P significantly above the levels cause by application of NMDA 
alone (Figure 6C).  Interestingly, application of AMPA (5 μM) alone also increased 
Cx36-P (Figure 6D).  These experiments support a role for NMDA-receptor mediated 
modulation of AII amacrine cell coupling via increased phosphorylation of Cx36 in AII 
amacrine cells.   It is unclear from these experiments how AMPA receptors drive 
increased Cx36 phosphorylation.  One simple explanation is that AMPA receptor-driven 
depolarization of AII amacrine cells may facilitate opening of NMDA receptors near 
Cx36 gap junctions, although these experiments cannot rule out other alternatives. 
 
ON-Bipolar cell activation and background light increments drive phosphorylation 
of Cx36 on AII amacrine cells 
 Finally, we tested whether activation of ON-type bipolar cells could drive 
increased phosphorylation of Cx36 gap junctions on AII amacrine cells.  Rod bipolar 
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cells provide the major glutamatergic input to AIIs on their fine dendrites, where the 
Cx36 gap junctions are located (Strettoi et al., 1992).  The experimental setup was the 
same as described for the above experiments using dark-adapted retina.  The mean level 
of Cx36-P was slightly higher in dark-adapted control pieces than in the above 
experiments (Figure 7A), but was still well reduced below levels seen in light-adapted 
retinas.  Addition of CPPG (200 μM), an mGluR6 antagonist which causes depolarization 
in ON-type bipolar cells (citations), significantly increased mean Cx36-P (Figure 7B, E) 
to levels similar to those in light-adapted retina.  At the same time as one retina-sclera 
piece was placed in Ames with CPPG added, another was place in Ames with L-AP4, an 
agonist of the mGluR6 receptor which hyperpolarizes ON-type bipolar cells.  Then, after 
the control (dark-adapted) and CPPG retina-sclera pieces were re-secured within the 
light-tight chamber, the remaining two pieces (in either control Ames or Ames with L-
AP4) were removed from the dark room and placed under the light-source (fluorescent 
lab lighting) used for light-adapted experiments for 15 minutes.  This period of increased 
background illumination also significantly increased Cx36-P (Figure 7C, E) back to 
typical light-adapted levels.  Inclusion of L-AP4 in the bath completely prevented this 
increase, and actually significantly reduced phosphorylation below control (dark-adapted) 
levels (Figure 7D, E).  That pharmacological inactivation of ON-type bipolar cells 
reduced phosphorylation further than dark-adaptation alone suggests that in this set of 
experiments dark-adaptation was incomplete, perhaps due to exposure to dim point-
sources of light in the dark room when the eyecup was removed from the light-tight 
chamber.  This is further supported by the observation that dark-adaptation in previous 
experiments was sufficient to reduce Cx36-P to the same levels as seen in L-AP4 in these 
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experiments.  These experiments provide evidence that increments in background 
lighting, mediated by ON-type bipolar cells, drive increased phosphorylation of Cx36 on 
AII amacrine cells.  This agrees nicely with previous experiments that demonstrated 
increased coupling between AII amacrine cells under increasing background illumination 
(Bloomfield et al., 1997; Bloomfield and Volgyi, 2004). 
 
Discussion 
 Although NMDA currents have been described in AII amacrine cells before 
(Hartveit and Veruki, 1997; Zhou and Dacheux, 2004), the physiological significance of 
these currents remain unknown.  The results of the present study now describe a role for 
these NMDA receptors in driving increased phosphorylation of Cx36 gap junctions on 
AIIs, thereby increasing cell-cell coupling in the AII amacrine cell network.  Indeed, 
driving increased phosphorylation of Cx36 under scotopic background illumination may 
be the primary purpose of NMDA receptors on AIIs, as our evidence indicates that they 
do not contribute to the light response of the cells under these conditions. 
 Our evidence indicates that the AII’s NMDA receptors are extrasynaptic, as 
EPSCs in AIIs triggered by voltage steps in rod bipolar cells were nearly abolished by 
AMPA receptor blockade.  This was confirmed by immunolabeling showing no 
relationship between NMDA receptors on AIIs and rod bipolar terminals or synaptic 
ribbons.  It is also in agreement with electrophysiological data reported by others 
showing that spontaneous EPSCs in AIIs were solely mediated by AMPA receptors 
(Veruki et al., 2003).  However, averaging of all rod bipolar-AII pairs did show a low-
amplitude, NBQX-resistant current with slow kinetics, as would be predicted for 
122 
extrasynaptic NMDA receptors (citations).  Since spillover of glutamate does occur at the 
rod bipolar-AII synapse (Veruki et al., 2006), it is possible that this residual current 
represents binding of spillover glutamate to the AIIs NMDA receptors.  Future 
experiments must be done to confirm this. 
 We found that the Cx36 and NMDA receptors are regularly colocalized or 
closely associated in AII dendrites, and a functional relationship between them was 
revealed by blockade of NMDA receptors in light-adapted retina, which reduced 
phosphorylation of Cx36 at Ser293.  This reduction in Cx36 phosphorylation indicates 
reduced coupling between AII amacrine cells (Kothmann et al., 2009).  The relationship 
between NMDA receptors and Cx36 was confirmed by the finding that activation of the 
receptors drives increased phosphorylation of Cx36 in dark-adapted retina.  This is very 
interesting, as AIIs should be hyperpolarized in the dark-adapted preparation.  In the 
absence of any depolarizing input, how do the NMDA receptors open?  It is known that 
NMDA receptors containing the NR2C or NR2D subunits are 5- to10-fold less sensitive 
to the Mg2+ block than are the other NMDA receptors (Monyer et al., 1994).  For 
instance, NR1-NR2A current responses to NMDA are reduced by ~80% by 0.5 mM Mg2+ 
at a holding potential of -60 mV, whereas NR1-NR2C responses are only reduced by 
~50% (Monyer et al., 1992).  Considering the physiological Mg2+ concentration in our 
Ames solution (1.2 mM Mg2+), we would predict that NMDA receptors on AIIs are NR1-
NR2C or NR1-NR2D heteromers.  It is also known that ambient extracellular glutamate 
in hippocampal slices is of sufficiently high concentration to activate NMDA receptors 
and contributes to the excitability of pyramidal neurons (Sah et al., 1989).  Similarly, in 
retina NMDA receptors contribute to the basal noise in retinal ganglion cells (Gottesman 
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and Miller, 2003).  In both of these examples the effect is observed at membrane 
potentials of  -70 mV or more, well below the resting membrane potential of an AII (-46 
mV, (Dunn et al., 2006).  Our data indicate that despite the lack of direct glutamatergic 
input on the AIIs fine dendrites in dark-adapted retina, NMDA receptors are still 
responsive to exogenous agonist, potentially because of receptor subtype and/or the 
relatively depolarized resting membrane potential of AII amacrine cells. 
 It is more straightforward to imagine the circumstances that would activate 
NMDA receptors on AII amacrine cells in vivo under scotopic conditions, when they are 
depolarized directly by glutamate released by rod bipolar cells.  Based on our results, we 
postulate that extracellular NMDA receptors, with their exceptional high affinity for 
glutamate (Olverman et al., 1984), sense the local excitation history in the vicinity of 
Cx36 gap junctions on AII dendrites.  Such a situation fits with the observed increase in 
AII-AII coupling when background illumination exceeds the rod photoreceptor threshold, 
as this is when rod bipolar cells presynaptic to AIIs begin to release glutamate and AIIs 
are transiently depolarized by AMPA receptor activation.  Further increases in 
background illumination within the scotopic range would cause larger numbers of rod 
bipolar cells to be active at a given time, further increasing extracellular glutamate and 
AII depolarization and thus further driving increased AII-AII coupling, as has been 
observed (Bloomfield et al., 1997; Bloomfield and Volgyi, 2004).  Our data support such 
a scenario, as pharmacological activation of ON-type bipolar cells and activation by a 
background light increment both drive increased phosphorylation of Cx36 gap junctions 
on the AII network, indicating increased AII-AII coupling. 
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 In light-adapted retina, AIIs receive significant input from coupled ON cone 
bipolar cells, sufficient to drive AII-mediated inhibition of OFF bipolar and ganglion 
cells (Manookin et al., 2008; Murphy and Rieke, 2008; Munch et al., 2009; van Wyk et 
al., 2009).  Depolarization from this input should facilitate NMDA receptor activation by 
ambient and/or spillover glutamate, leading to increased Cx36 phosphorylation.  This will 
be opposed by dopamine-driven dephosphorylation of Cx36 in daytime, light-adapted 
retina (Kothmann et al., 2009).  The conflicting actions of these two pathways likely 
account for the heterogeneous phosphorylation of Cx36 gap junctions that we observe in 
light-adapted retina-sclera preparations.  It is unknown if this same heterogeneity exists 
in vivo, as the bath volume (4 mL) used in our pharmacology experiments may dilute 
effective dopamine concentrations.  In addition or perhaps alternatively, the observed 
heterogeneity may be due to differential regulation of AII-AII gap junctions and AII-cone 
bipolar gap junctions, as has been demonstrated (Mills and Massey, 1995).  Our 
techniques do not currently distinguish between these gap junctions, but it seems likely 
that AII-AII gap junctional coupling may be preferentially decreased while AII-cone 
bipolar gap junctional coupling remains somewhat intact, given the existence of ON cone 
bipolar driven inhibition of ganglion cells via AII amacrine cell activation (Manookin et 
al., 2008; Murphy and Rieke, 2008; Munch et al., 2009; van Wyk et al., 2009) and the 
lesser effect of dopamine on AII-cone bipolar gap junctions (Xia and Mills, 2004).  This 
could be due to expression of Cx45 on the ON bipolar cell side of these junctions (Han 
and Massey, 2005; Dedek et al., 2006), or the selective impact of cGMP-dependent 
signaling on the ON bipolar cell side of the gap junction only (Mills and Massey, 1995; 
Xia and Mills, 2004), or both. 
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 Our data show that the effects of glutamate receptor blockade on Cx36 
phosphorylation are not due to indirect modulation of extracellular dopamine in the 
retina, as they persist when the dopaminergic input to AII amacrine cells is blocked.  
Further evidence for this comes from the same set of experiments, since blockade of 
AMPA and NMDA receptors should reduce activation of the dopaminergic amacrine cell 
(Zhang et al., 2007; Hoshi et al., 2009), which would reduce extracellular dopamine and 
should increase Cx36 phosphorylation on AIIs (Kothmann et al., 2009).  However, we 
observe the opposite; Cx36 phosphorylation was reduced in these experiments, whether 
or not D1 dopamine receptors were blocked.  Thus we conclude from the experiments 
presented here and those conducted previously (Kothmann et al., 2009) that two 
pathways, one driving increased phosphorylation and mediated by NMDA receptor 
activation and the other driving decreased phosphorylation and mediated by dopamine 
signaling, are responsible for the inverted U-shaped pattern of coupling in the AII 
amacrine cell relative to background illumination.  Furthermore, we infer from our data 
that there must be constitutive phosphatase activity which drives dephosphorylation of 
Cx36 in dark-adapted retina.  The identity of the phosphatase and whether its activity is 
modulated remains unknown at present. 
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Chapter 5 
 
Discussion 
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 The experiments detailed in the previous chapters have significantly advanced 
our understanding of how signaling methods in the retina contribute to the regulation of 
gap junctional coupling in a particular retinal neuron, the AII amacrine cell.  In order to 
reach this new level of understanding, we first developed and characterized phospho-
specific antibodies against key residues of the gap junction protein Cx36.  We then 
showed that light adaptation state and acute light exposure modulate the phosphorylation 
state of these residues in fish retina.  These initial experiments highlighted the need for a 
method to study a retinal neuron expressing Cx36 that we could repeatedly identify.  We 
chose the AII amacrine cell of mammalian retina for further study because it is easily and 
diffusely immunolabeled by antibodies against calretinin and because its coupling state is 
strongly modulated by dopamine signaling.  Using rabbit retina to study regulation of the 
AII amacrine cell coupling we described the relationship between phosphorylation of 
Cx36 and coupling through these gap junctions.  We discovered that dopamine-
stimulated uncoupling of the AII is, as predicted, mediated by PKA activation, but that 
this pathway triggers dephosphorylation of Cx36 the requires activation of PP2A.  Our 
experiments in this system also indicated that phosphorylation appears to modulate 
coupling by altering the channel properties of Cx36, rather than by alteration of 
trafficking of the protein.  They also indicated that coupling is regulated locally at the 
level of individual gap junction plaques, rather than on a cell-by-cell basis.  Finally, we 
demonstrated that increased coupling between AII amacrine cells is driven by activation 
of NMDA receptors and activation of CamKII. This increase in coupling was caused by 
activation of ON type bipolar cells by light increments. 
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Our findings show that two pathways, dopamine D1 receptor signaling and 
NMDA receptor activation, drive phosphorylation of Cx36 in opposite directions in AII 
amacrine cells.  Together these two pathways can account for the characteristic inverted 
‘U’-shaped pattern of AII amacrine cell coupling in relation to background illumination.  
Additionally, we found that dark-adaptation strongly reduced Cx36 phosphorylation.  
These observations, along with the presence of two diametrically opposed pathways, 
provide the first independent confirmation of the inverted ‘U’-shaped coupling-light 
relationship. 
Horizontal cells in the rabbit retina also display an inverted ‘U’-shaped 
coupling pattern in relation to background illumination (Xin and Bloomfield, 1999), and 
are also uncoupled by dopamine through D1 receptor-like signaling (Piccolino et al., 
1984; Lasater, 1987).  Based on these similarities to the AII amacrine cell network, we 
would predict that they also show increased coupling driven by presynaptic activity in 
photoreceptors.  Regulation of horizontal cell coupling through phosphorylation of gap 
junction proteins they express, such as connexin 50 (O'Brien et al., 2006), remains a 
viable hypothesis at present.  However, since neither horizontal cell uses Cx36 gap 
junctions, the exact intracellular cascades leading to increased coupling would not 
necessarily be the same.  Indeed, other work in our lab has shown that regulation of 
coupling between zebrafish cone photoreceptors is also dependent on dopamine 
signaling, but that PKA activation increases coupling, exactly opposite of what we 
observe in AII amacrine cells (O'Brien et al., 2004).  Coupled with our results presented 
here, it becomes clear that regulation of Cx36 is cell-type specific, and must be studied 
further on a cell-by-cell basis. 
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 Many questions still remain about the role of phosphorylation in regulating 
Cx36-mediated coupling. Does phosphorylation itself alter the conformation of the 
protein, thereby changing the conductance or open probability of the channel?  
Alternatively, does it alter the affinity of Cx36 for protein binding partners, which then 
modulate coupling?  Indeed, the two possibilities are not mutually exclusive, but solving 
them presents numerous technical challenges requiring careful biochemistry, 
electrophysiology, and structural studies. 
 Further questions exist about coupling in the AII amacrine cell network as 
well.  Of great interest is whether regulatory pathways within the AII amacrine cell 
selectively modulate AII-AII gap junctions differently than they regulate AII-cone 
bipolar gap junctions.  Anecdotally, I have observed that antagonism of NMDA receptors 
often leaves a population of small gap junctions on AIIs well phosphorylated.  Many of 
these gap junctions do not appear to be at AII dendritic crossings, indicating that they are 
likely to be AII-cone bipolar gap junctions.  Future studies are needed to determine if this 
is a reliable effect, and will require careful analysis and more concrete identification of 
AII-cone bipolar gap junctions.  Additionally, before concluded differential regulation 
within AII amacrine cells, it must be shown that any selective effect of NMDA receptor 
antagonism is not selectively modulating Cx36 hemichannels on the bipolar cell side of 
the gap junction.  Such channels have been reported in ON-cone bipolar cells that appear 
to be coupled to AIIs (Han and Massey, 2005).  Most studies agree that Cx45 is 
expressed by the majority of bipolar cell types that couple to AIIs and forms heterotypic 
gap junctions with Cx36 on the AII side (Han and Massey, 2005; Maxeiner et al., 2005; 
Dedek et al., 2006), but the question of whether the AII-cone bipolar gap junctions are 
130 
homotypic, heterotypic, or Cx36/Cx45 bi-homotypic is still somewhat debated (Li et al., 
2008). 
The experiments presented in this work now provide a logical, integrated 
framework for studying regulation of Cx36-mediated coupling in other neuronal systems, 
where it is widely expressed, as well as in pancreatic β cells where it is involved in 
regulation of insulin secretion (Serre-Beinier et al., 2008; Wellershaus et al., 2008).  In 
these systems, coupling can now be easily assessed through use of the phospho-specific 
antibodies developed and used in this work.  Additionally, our results explain the 
mechanisms that underlie long-standing yet enigmatic observations of regulation of AII 
amacrine cell coupling by background illumination levels. 
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